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https://doi.org/10.1016/j.stem.2020.05.004SUMMARYCardiomyocytes (CMs) from human induced pluripotent stem cells (hiPSCs) are functionally immature, but
this is improved by incorporation into engineered tissues or forced contraction. Here, we showed that tri-
cellular combinations of hiPSC-derived CMs, cardiac fibroblasts (CFs), and cardiac endothelial cells also
enhance maturation in easily constructed, scaffold-free, three-dimensional microtissues (MTs). hiPSC-
CMs in MTs with CFs showed improved sarcomeric structures with T-tubules, enhanced contractility, and
mitochondrial respiration and were electrophysiologically more mature than MTs without CFs. Interactions
mediating maturation included coupling between hiPSC-CMs and CFs through connexin 43 (CX43) gap junc-
tions and increased intracellular cyclic AMP (cAMP). Scaled production of thousands of hiPSC-MTs was
highly reproducible across lines and differentiated cell batches. MTs containing healthy-control hiPSC-
CMs but hiPSC-CFs from patients with arrhythmogenic cardiomyopathy strikingly recapitulated features
of the disease. Our MT model is thus a simple and versatile platform for modeling multicellular cardiac dis-
eases that will facilitate industry and academic engagement in high-throughput molecular screening.INTRODUCTION
Dialogue between stromal, vascular, and tissue-specific cells is
essential for maintaining tissue homeostasis. Aside from862 Cell Stem Cell 26, 862–879, June 4, 2020 ª 2020 The Author(s).
This is an open access article under the CC BY license (http://creativeproviding nutrition, growth factors, extracellular matrix (ECM),
and hormones, three-dimensional (3D) biophysical interactions
with stromal cells are also necessary to ensure proper organ
function. Human induced pluripotent stem cells (hiPSCs) canPublished by Elsevier Inc.
commons.org/licenses/by/4.0/).
Figure 1. Differentiation, Expansion, and Characterization of hiPSC-Derived Cardiac Fibroblasts
(A) Protocol for hiPSC differentiation into cardiac fibroblasts with bright-field images at indicated times (d, days) for CTRL1-hiPSCs (LUMC0020iCTRL-06). BAC,
BMP4 + activin-A + CHIR99021; BXR, BMP4 + XAV939 + retinoic acid; F, FGF2; S, SB431542. Scale bar: 100 mm.
(legend continued on next page)
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capturing the donor genome, but in most cases, differentiated
derivatives are immature. We hypothesized that the absence of
tissue-specific stromal and vascular cells may contribute to
maturation failure and here used the heart as an exemplar to
examine the effect of cardiac stromal cells on hiPSC-cardiomyo-
cytes (hiPSC-CMs).
The adult heart contains 30% contractile CMs, the remaining
non-CM fraction being cardiac endothelial cells (ECs), vascular
stromal cells, and cardiac fibroblasts (CFs) (Pinto et al., 2016).
Human embryonic stem cells (hESCs) (Kehat et al., 2001; Mum-
mery et al., 2003) and hiPSCs (Denning et al., 2016) differentiate
to CMs, which resemble human fetal rather than adult CMs in
their structural, functional, and gene expression profiles (Gupta
et al., 2010; van den Berg et al., 2015; Xu et al., 2009; Yang
et al., 2014). Nevertheless, they can recapitulate phenotypical
traits of many genetic cardiac disorders in vitro (Carvajal-Vergara
et al., 2010; Caspi et al., 2013; Dell’Era et al., 2015; Dudek et al.,
2013; Giacomelli et al., 2017c; Moretti et al., 2010; Te Riele et al.,
2017; Siu et al., 2012; Wang et al., 2014) and to some extent pre-
dict cardiotoxicity of pharmacological compounds and key path-
ways in disease (Cross et al., 2015; Sala et al., 2017; van Meer et
al., 2019). Relatively mature hiPSC-CMs have only been
convincingly observed in 3D scaffold-based cultures or engi-
neered heart tissues (EHTs) in vitro (Lemoine et al., 2017; Man-
nhardt et al., 2016; Ronaldson-Bouchard et al., 2018; Tiburcy
et al., 2017) with escalating forced contraction enhancing matu-
ration such that transverse (T-) tubule-like structures become
evident (Ronaldson-Bouchard et al., 2018; Tiburcy et al., 2017).
T-tubules normally develop postnatally to regulate Ca2+ homeo-
stasis, excitation-contraction coupling, and electrical activity of
the heart (Brette and Orchard, 2007). However, EHTs require
specific expertise, specialized apparatus, gelation substrates,
and analysis tools (Mathur et al., 2015) and are thus complex so-
lutions for most academic laboratories and pharma applications.
Moreover, monotypic cell configurations do not recapitulate how
stromal or vascular cells might affect the behavior of CMs and
mediate disease or drug-induced phenotypes.
Here, we addressed these issues by generating multicell-type
3D cardiac microtissues (MTs) starting with just 5,000 cells. We
demonstrated previously that hiPSC-ECs derived from cardiac
mesoderm affect hiPSC-CMs in 3D MTs (Giacomelli et al.,
2017b) and found here that inclusion of hiPSC-CFs further
enhanced structural, electrical, mechanical, and metabolic
maturation. CFs mainly originate from the epicardium (Tallquist
and Molkentin, 2017), the outer epithelium covering the heart.
They play crucial roles in cardiac physiology and pathophysi-
ology (Furtado et al., 2016; Kofron et al., 2017; Risebro et al.,
2015), contributing to scar tissue formation after myocardial(B) Representative immunofluorescence images of WT1, TBX18, COL1A1 (red), an
hiPSCs, ACFs, and SFs. Nuclei stained with DAPI (blue). Scale bar: 20 mm.
(C) Heatmap showing qPCR analysis of fibroblast (GJA1, ITGA4, COL1A2, COL1
hiPSC-CFs from hiPSC lines indicated and ACFs and SFs. Values normalized to
(D) Principal-component (PC) analysis of hiPSC-CMs, primary human fetal- (hu
hiPSC-EPIs and primary human adult (ACFs), fetal (huF-CFs) and hiPSC-derived
individual samples; colors different cell types.
(E) Heatmap showing hierarchical clustering of 4,266 DEGs (PFDR% 0.05) across
(F) GO analysis of cell-lineage-specific gene clusters.
864 Cell Stem Cell 26, 862–879, June 4, 2020infarction (Rog-Zielinska et al., 2016). Theymaintain and remodel
the ECM, contributing to the integrity and connectivity of the
myocardial architecture (Dostal et al., 2015). Although non-excit-
able themselves, CFs modulate active and passive electrical
properties of CMs (Klesen et al., 2018; Kofron et al., 2017; Maho-
ney et al., 2016; Ongstad and Kohl, 2016). CFs have also been
implicated in contractility of hiPSC-CMs in 3D self-assembled
(scaffold-free) MTs composed of hiPSC-CMs, primary human
cardiac microvasculature ECs, and primary human CFs (Pointon
et al., 2017). MTs have to date only been generated using pri-
mary stromal cells, which impacts reproducibility and supply.
By replacing primary ECs and CFs with hiPSC counterparts,
we generated thousands of scaffold-free miniaturized cardiac
MTs (CMECFs) containing all cellular components in defined ra-
tios and observed enhanced hiPSC-CMmaturation. We demon-
strated that CFs, expressing connexin 43 (CX43) gap junction
protein, were most effective in supporting hiPSC-CM matura-
tion, and this was mediated by cyclic AMP (cAMP). Skin fibro-
blasts (SFs), which do not express CX43, and CFs in which
CX43 was knocked down were unable to couple to hiPSC-
CMs and did not improve maturation. Single-cell (sc) RNA
sequencing (RNA-seq) showed that signals from both cardiac
ECs and CFs likely contributed to increasing intracellular cAMP
in hiPSC-CMs and this was recapitulated by adding dibutyryl
(db) cAMP, a cell-permeable analog of cAMP. MTs in which con-
trol CFs were replaced by hiPSC CFs carrying a mutation in the
desmosomal protein PKP2 that causes arrhythmogenic cardio-
myopathy (ACM) strikingly showed CX43 reduction and cardiac
arrhythmic behavior despite the CMs being healthy. This illus-
trates that CFs are crucial in controlling adjacent CM behavior
and that CFs were integral contributors to the ACM phenotype.
RESULTS
hiPSC-Derived Epicardial Cells Differentiate into CFs
In Vitro
Epicardial cells (EPIs) contribute more than 80% of CFs in the
heart (Tallquist and Molkentin, 2017). To generate CFs, we first
differentiated hiPSC lines into EPIs, as previously described
(Guadix et al., 2017; Figure 1A). EPIs emerged with typical
epithelial cobblestone-like morphology reaching confluence on
day 12 of differentiation (Figure 1A). Immunofluorescence (IF)
confirmed nuclear expression of WT1 and TBX18 (Figure 1B).
To induce CF differentiation, hiPSC-EPIs were dissociated on
day 12 and re-plated in mediumwith basic fibroblast growth fac-
tor (FGF2) (10 ng/mL) for 8 days, refreshing on day 13 and every
2 days thereafter (Figure 1A). Cells became typically mesen-
chymal (Figure 1A). On day 21, hiPSC-CFs were expanded for
an additional 8 days in FGM3 medium. IF confirmed the EPI-d CX43 (green) of hiPSC-EPIs and hiPSC-CFs from CTRL1, CTRL2, and LQT1
A1, and POSTN) and EPI (GJA1, WT1, and TBX18) genes in hiPSC-EPIs and
RPL37A. n = 3.
F-ECs) and hiPSC-cardiac ECs (hiPSC-ECs), primary human adult SFs, and
CFs (hiPSC-CFs) based on RNA-seq profiles using all genes. Dots represent
different cell types showing cell-lineage-specific gene clusters.
Figure 2. Cardiac Fibroblasts Promote Structural Maturation of hiPSC-CMs in Microtissues
(A) Schematic showing cellular composition of cardiac MT groups. Cell percentages (black) and numbers (gray) are indicated.
(B and C) Representative immunofluorescence images for (B) cardiac sarcomeric proteins TNNI (green) and ACTN2 (red) in MTs (scale bar: 10 mm) and (C) ACTN2
(red) in cells dissociated from MTs (scale bar: 20 mm). Nuclei are stained with DAPI (blue).
(legend continued on next page)
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TBX18 and expression of collagen type alpha1 (COL1A1). By
day 29, hiPSC-CFs expressed multiple fibroblast genes (GJA1,
ITGA4, COL1A1, COL1A2, and POSTN) and reduced WT1 and
TBX18 (Figure 1C). The differentiation protocol was robust and
reproducible in three independent hiPSC lines (Figures 1B and
1C); all hiPSC-CFs exhibited similar mRNA and protein marker
expression and were more similar to adult CFs (ACFs) than to
SFs, which were characterized by negligible expression of the
gap junction protein CX43 (GJA1 gene) and high expression of
collagen markers (COL1A1 and COL1A2; Figures 1B and 1C).
Principal-component (PC) analysis of whole-transcriptome
RNA-seq of hiPSC-CMs, primary human fetal-ECs (huF-ECs)
and hiPSC-cardiac ECs (Giacomelli et al., 2017a), SFs, hiPSC-
EPIs, and primary human ACFs, huF-CFs, and hiPSC-CFs
confirmed striking genome-wide expression correspondence
between primary human cardiac cells and their hiPSC-derived
equivalents (Figure 1D). Hierarchical clustering of cell-lineage-
specific signature genes identified gene clusters upregulated in
each of the different cell types (Figure 1E). Gene Ontology (GO)
terms for heart and vasculature development, cell junction orga-
nization, and collagen metabolic process were associated with
hiPSC-CMs, ECs, EPIs, and CFs, respectively (Figure 1F; Table
S1). The data thus showed shared cellular identities between pri-
mary cardiac cells and their hiPSC-derived equivalents and
distinct differences between each cell subtype.
Establishment of 3D Microtissue Model Composed of
hiPSC-CMs, hiPSC-ECs, and CFs or Dermal Fibroblasts
Given their distinct identities, we used hiPSC-derived cardiac
cells to form 3D MTs containing hiPSC-CMs and hiPSC-cardiac
ECs, derived as previously from a common cardiac mesoderm
precursor (MT-CMEC; termed here CMECs; Giacomelli et al.,
2017a, 2017b), hiPSC-CMs and hiPSC-CFs (CMFs), or, addition-
ally, hiPSC-CMs, hiPSC-ECs, and various types of fibroblasts.
These were hiPSC-CFs (CMECFs), ACFs (CMEC ACFs) and
adult SFs (CMEC SFs; Figure 2A). MTs were aggregated as
spheroids from 5,000 cells in V-bottom 96-well microplates, re-
freshed every 3 days with vascular endothelial growth factor
(VEGF) (CMECs), FGF2 (CMFs), or VEGF and FGF2 (CMECFs,
CMEC ACFs, and CMEC SFs) and cultured for 21 days.
We first examined overall morphology and cellular architecture
by IF for CM (cardiac troponin I; TNNI), EC (CD31), and fibroblast
(COL1A1) markers (Figure S1A) using a computational frame-
work developed in house for 3D semi-automated image pro-
cessing and segmentation. MTs containing fibroblasts were
similar in size and total cell number (Figure S1B), whereas
CMECs were smaller, containing fewer cells despite the same
input cell number. The percentages of the different cell types
(Figure S1C) were comparable among MT groups and reflected(D) Representative transmission electron microscopy (TEM) images showing sar
(E) TEM images showing caveolae (c), T-tubule like structures (t), Z-lines (Z), I-b
arrows) in CMECFs. Scale bar: 0.5 mm.
(F) Sarcomere organization (sarcomere alignment index; n > 45 areas from 3MTs
*p < 0.001) from immunofluorescence analysis in MTs from CTRL1 hiPSCs.
(G) Sarcomere length in hiPSC-CMs dissociated from MTs. n > 28 areas from at
(H) Sarcomere length from TEM in MTs from CTRL1 (n > 41 areas from at least 2
ANOVA with Dunnett’s multiple comparisons test is shown.
866 Cell Stem Cell 26, 862–879, June 4, 2020the input used for MT formation. Although relatively more
COL1A1+ cells were found in CMEC SFs (Figure S1C), the per-
centage of proliferating cells over time remained low in all MT
groups with few or no Ki-67+COL1A1+ cells (Figures S1D and
S1E). Time-lapse videos of CMEC and CMECF formation
showed that CMECFs formed faster and were rapidly more
compact than CMECs, suggesting that fibroblasts facilitated ag-
gregation, likely through enhanced cell-cell adhesion (data not
shown). Average distance between nuclei indicated that nuclei
were indeed more densely packed in MTs containing CFs and
ECs than in CMECs (Figure S1F). CM nuclei in CF-containing
MTs were larger than in other MT groups (Figure S1G), suggest-
ing that hypertrophy associated with maturation had been initi-
ated. We next examined salient features of adult CM function,
namely (ultra)structure, electrophysiology, and mechanical
contraction.
CFs Promote Structural Maturation of hiPSC-CMs in
Microtissues
Immunostaining for cardiac sarcomeric proteins TNNI and acti-
nin alpha-2 (ACTN2) in MTs revealed better sarcomere develop-
ment and organization inMTs containing CFs than in CMECs and
CMEC SFs from three independent hiPSC lines, as indicated by
sarcomere alignment index and length (Figures 2B, 2F, and S2A–
S2C). This was confirmed by IF on CMs from dissociated MTs
(Figures 2C and 2G) and transmission electron microscopy
(TEM) (Figures 2D and 2H). TEM also showed more mature
hiPSC-CM ultrastructure in CMECFs, including the presence of
caveolae, elongated and enlarged mitochondria with complex
cristae, and elongated tubular myofibrils consisting of well-orga-
nized sarcomeres with regular Z-lines, I-bands, and H-zones;
M-lines and T-tubule-like structures (Eisner et al., 2017) were
also visible (Figures 2E and S2D).
Comparison of bulk- and sc-RNA-seq with published datasets
showed that CMs in CMECFs clustered closely to adult human
CMs, whereas CMs in 2D and in CMECs clustered separately
as immature cells (Figure 3A). scRNA-seq analysis of CMs in
2D versus CMECFs confirmed enhanced CM structural matura-
tion in CMECFs, with increased expression of key cardiac sarco-
meric genes TNNT2, MYL2, MYL3, MYL4, TNNI1, TNNI3, DES,
and also TCAP, important for sarcomere assembly and T-tubule
structure and function in the mammalian heart (Ibrahim et al.,
2013; Valle et al., 1997; Figures 3B and S3A–S3D; Table S2).
Furthermore, bulk RNA-seq confirmed that MTs containing
hiPSC-CFs were globally more similar to CMEC ACFs than
CMEC SFs (Figure 3C). Of note, least biological variability was
observed when MTs were entirely hiPSC derived (Figure 3C).
Differentially expressed genes (DEGs) were identified between
hiPSC-CMs, CMECs, CMECFs, CMEC ACFs, and CMEC SFs
(Figure S3E). Unsupervised clustering of DEGs identified genescomeres in different MTs. Scale bar: 1 mm.
ands (I), H-zones (H), and elongated mitochondria with complex cristae (red
per group; *p < 0.05) and sarcomere length (n > 47 areas from 3MTs per group;
least 3 independent slides per MT group.
independent stitches per group; *p < 0.05). Data are mean ± SEM. One-way
Figure 3. Single-Cell and Bulk Transcriptome Profiling of Microtissues
(A) PC analysis of single-cell (sc) and bulk RNA-seq of hiPSC-CMs at day 20 (single cell CMs; CMs), bulk CMECs (CMECs), and sc and bulk CMECFs (single cell
CMECFs; CMECFs) from this study, with bulk hPSC-CMs (day 20), bulk primary human fetal heart (fetal), bulk hPSC-CMs (1 year), and primary human adult heart
(adult) from RNA-seq in Kuppusamy et al. (2015); CM cluster). Colors represent different samples.
(legend continued on next page)
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(Figure S3F). CMECFs and CMEC ACFs showed common mo-
lecular signatures characterized by genes upregulated in cluster
5 (Figure 3D; Table S3), which were not upregulated in CMEC
SFs. GO analysis showed enrichment in terms for heart contrac-
tion, cardiac conduction, regulation of membrane potential, car-
diac muscle cell development, regulation of the force of heart
contraction, and regulation of ion transmembrane function (Fig-
ure 3E; Table S3). Kyoto Encyclopedia of Genes and Genomes
(KEGG) analysis showed that the pathway ‘‘adrenergic signaling
in cardiomyocytes’’ was enriched among genes commonly upre-
gulated in CMECFs and CMEC ACFs (cluster 5; Figure 3F; Table
S3). Heatmaps of genes associated with GO terms of heart
contraction and regulation of ion transmembrane transport and
KEGG pathway adrenergic signaling in cardiomyocytes (Figures
3G–3I) showed higher expression of sarcomere proteins, ion
channels, and adrenergic receptors in CMECFs and CMEC
ACFs compared to CMECs and CMEC SFs.
These findings suggested that both adult- and hiPSC-CFs
promote maturation of hiPSC-CMs in MTs such that they display
multiple postnatal features.
CFs Promote Electrical Maturation and Enhance
Mechanical Contraction of hiPSC-CMs in Microtissues
To determine whether structural maturation was accompanied
by electrical maturation, we measured action potentials (APs)
in CMs from dissociated MTs using patch-clamp electrophysi-
ology (Figures 4A–4D and S4A). hiPSC-CMs from CMECFs
and CMEC ACFs clearly showed similar and improved electro-
physiological maturity than hiPSC-CMs from CMECs, CMFs,
and CMEC SFs, with many CMs exhibiting fast transient repolar-
ization after the AP peak (referred to as an AP ‘‘notch’’; Figures
4A and 4B), reflecting expression of the typical transient outward
potassium current (Ito), in agreement with upregulation of Ito
genes KCND3 and KCNA4 (Figure 3H); moreover, they had
more negative resting membrane potentials (RMP), increased
AP amplitudes and prolonged AP duration at 90% of the repolar-
ization (APD90) (Figure 4C), although upstroke velocity was
increased in all fibroblast-containing MTs compared to CMECs
(Figure 4D). These differences between CMECFs and CMECs
were confirmed by sharp electrode electrophysiology on whole
MTs (Figures S4B and S4C). Incidentally, sharp electrodes de-
tected cells with AP profiles similar to those reported previously
as resulting from heterocellular coupling between CMs and CFs
(Klesen et al., 2018) through gap junctions in adult native heart
tissue (Pellman et al., 2016; Stewart, 1978; Figure S4D).
Immature sarcomere structure is often associated with low
contractility. To determine whether sarcomere maturation was
accompanied by mechanical maturation, we investigated spon-(B) Volcano plot and heatmaps displaying sorted log2 fold-change (FC) and adjuste
based on their scRNA-seq profiles. Log2FC > 0 indicates upregulated genes in t
upregulated genes in the CM cluster of hiPSC-CMs versus CMECFs.
(C) Spearman’s correlation heatmap of hiPSC-CMs, CMECs, CMECFs, CMEC A
(D) Heatmap showing gene expression in eight gene clusters from the consensu
(E) GO Biological Process terms enriched in gene clusters from consensus matri
(F) KEGG pathways enriched in gene clusters from consensus matrix (padj < 0.05
(G–I) Heatmaps showing expression of genes selected fromGO: heart contraction
signaling in cardiomyocytes (I).
868 Cell Stem Cell 26, 862–879, June 4, 2020taneous contractile activity of MTs (Sala et al., 2018; Figures 4E–
4H). Representative contraction recordings of MTs are shown in
Figure 4E. The beat-to-beat intervals were similar in CMECFs
and CMEC ACFs and lower than in MTs without ECs or CFs or
with SFs (Figure 4F). Contraction duration normalized to beating
rate was prolonged (Figure 4G), in agreement with the prolonged
APD90, suggesting that both ECs and CFs were necessary to
enhance contractility. Contraction amplitude in CMECs, which
correlates with force of contraction (Sala et al., 2018), was similar
to CMECSFs andCMFs but lower than inMTswith both CFs and
cardiac ECs (Figure 4H). To further analyze contractility, we
quantified contraction and relaxation in paced MTs using vector
flow analysis. Both parameters were significantly faster in
CMECFs than in CMECs, as indicated by the maximum contrac-
tion velocity and accelerationmeasured at increasing pacing fre-
quencies (Figure S4E; Video S1); this suggested greater func-
tional contractility in CMECFs, in line with their improved
sarcomere organization. In addition, line integral analysis of the
MTs allowed the direction of propagation waves to be depicted
(Hayakawa et al., 2012). CMECFs and CMEC ACFs displayed
higher contraction velocities and greater coordination of the
line integral patterns within each tissue compared to the other
MT types (Video S2).
To determine whether improvedmechanical performance was
accompanied by improved Ca2+ handling, we examined Ca2+
transients using a Ca2+-sensitive dye in paced MTs (Figures 4I
and 4J). MTs with CFs showed different transient profiles (Fig-
ure 4I), with increased time to peak and faster decay than
CMECs and CMEC SFs (Figure 4J). To investigate sarcoplasmic
reticulum (SR) Ca2+ content, we examined Ca2+ transients
induced by caffeine puffs in CMECs and CMECFs. The ampli-
tude of caffeine-induced Ca2+ transients was greater in CMECFs
than CMECs (Figures S4F and S4G), indicating higher SR Ca2+
storage, likely linked to higher expression of key Ca2+-handling
protein genes like CASQ2, CALM2, PLN, and TRDN (Figures
3G and 3H).
We then determined whether CMECFs could capture negative
and positive inotropic responses to known pharmacological
agents, verapamil and Bay K-8644, respectively (Figures S4H–
S4J). Contraction amplitude decreased upon verapamil treat-
ment in a concentration-dependent manner (Figure S4H), as ex-
pected from the block of the L-type calcium channel; this was
paralleled by decreased velocity and acceleration of both
contraction and relaxation (Figure S4J). By contrast, prolonged
relaxation duration was observed upon treatment with the
L-type calcium channel agonist Bay K-8644 (Figure S4I).
We conclude that (adult- and hiPSC-derived) CFs promote
electrical and mechanical maturation of hiPSC-CMs in 3D MTs,
with high reproducibility across lines, batches, and samplesd p values showing expression of selected genes for hiPSC-CMs andCMECFs
he CM cluster of CMECFs versus hiPSC-CMs, whereas log2FC < 0 indicates
CFs, and CMEC SFs based on bulk RNA-seq.
s matrix across CMECs, CMECFs, CMEC ACFs, and CMEC SFs.
x (padj < 0.05).
).
(G); GO: regulation of ion transmembrane transport (H); and KEGG: adrenergic
Figure 4. Cardiac Fibroblasts Promote Electrical Maturation and Enhance Mechanical Contraction of hiPSC-CMs in Microtissues
(A) Representative action potential (AP) traces recorded from single hiPSC-CMs dissociated from MT groups indicated, stimulated at 1 Hz.
(B) Bar graph showing the fraction of APs with the Ito ‘‘notch’’ (red).
(C and D) APs recorded in single hiPSC-CMs from different MT groups (see A). (C) RMP, resting membrane potential; APA, amplitude; APD90, action potential
duration at 90% of repolarization; (D) Vmax, maximum upstroke velocity in APs measured with dynamic clamp (n > 18; single CMs dissociated from 2–5 inde-
pendent MT batches per group; *p < 0.05).
(E) Representative contraction traces in spontaneously beating MTs. For graphical visualization, amplitude was normalized to each respective maximum
amplitude.
(F and G) Inter-beat interval (IBI) (F) and normalized contraction duration (G) in spontaneously beating MTs. n > 26; MTs from 3 independent batches per group;
*p < 0.0001.
(H) Contraction amplitude in spontaneously beating MTs. a.u., arbitrary units. n > 7; MTs; *p < 0.05. One-way ANOVA with Fisher’s least significant difference
(LSD) test is shown.
(I) Representative Ca2+ transients in MTs stimulated at 1.5 Hz.
(J) Ca2+ transient parameters (time to peak, peak to 90% decay time, and peak to half decay time) of MTs stimulated at 1.5 Hz. n > 15; MTs from 3 independent
batches per group. *p < 0.0001. One-way ANOVA with Dunnett’s multiple comparisons test is shown. Data in bar graphs are mean ± SEM.
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of both cardiac ECs and CFs are essential to induce these ef-
fects. Finally, CMECFs show drug responses similar to those in
EHTs (Mannhardt et al., 2016).
Metabolic Maturation of hiPSC-CMs in Microtissues
To determine whether structural, electrical, and contractile
maturation in MTs was accompanied by changes in metabolism,
we first examined metabolic gene signatures using scRNA-seq
analysis of CMs in CMECFs versus 2D culture. scRNA-seq
showed reduction in glycolysis- and increase in beta-oxidation-
and tricarboxylic acid cycle (TCA)-associated genes in CMs in
CMECFs (summarized schematically in Figure 5A and Table
S4). Mitochondrial respiration, glycolytic activity, and the con-
centration of intracellular metabolites in MTs were then analyzedby Seahorse XF-96 and nuclear magnetic resonance (NMR)
spectroscopy (Figures 5B, 5C, S5A, and S5B). CMECFs and
CMEC ACFs showed comparable mitochondrial respiration
and glycolytic activity that was significantly higher compared
to CMECs (Figures 5B and 5C). Intracellular levels of several me-
tabolites in CMECFs and CMEC ACFs were comparable but
different from CMECs, such as higher ATP and lower lactate,
as well as high uptake of glutamine from the medium, indicating
higher mitochondrial respiration (Figures S5A and S5B). By
contrast, CMECs were less metabolically active and had a
greater preference for glycolysis over mitochondria respiration,
as shown by higher intracellular lactate and lower intracellular
ATP, as well as lower glucose uptake and low net release of
lactate and glutamine (Figure S5A). In addition, a small intracel-
lular pool of lactate (Figure S5A) and high glycolytic activity inCell Stem Cell 26, 862–879, June 4, 2020 869
Figure 5. Metabolic Maturation of hiPSC-CMs in Microtissues
(A) Schematic showing metabolic pathways with significantly upregulated (in red) and downregulated (in blue) genes (log2FC; p.adj < 0.05) in the CM cluster of
CMECFs versus hiPSC-CMs based on their scRNA-seq profiles. When applicable, heart andmuscle isoformswere selected, although other organ isoforms were
excluded.
(legend continued on next page)
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produced by the ECs and the CFs was shuttled to the CMs for
further oxidation. In line with NMR data, scRNA-seq showed
that LDHA and LDHB genes were down- and upregulated,
respectively, in CMs in CMECFs (Figure 5A).
The enhanced mitochondrial respiratory capacity in CMECFs
and CMCF ACFs indicated that tri-cellular crosstalk between
cardiac-specific cells is needed to enhance metabolic matura-
tion in MTs.
Mechanisms Underlying hiPSC-CM Maturation in
Microtissues with CFs and ECs Involve CX43 Gap
Junctions and cAMP
Because MTs with CFs and ECs most effectively promoted
hiPSC-CM maturation, we investigated underlying mechanisms
in more detail in CMECs with CFs. Bulk RNA-seq revealed that
fibroblast-containing MTs showed common molecular signa-
tures characterized by genes upregulated in cluster 3 and cluster
6 (Figure 3D).
KEGG analysis showed that the cAMP signaling pathway was
enriched in cluster 3 and, as mentioned above, adrenergic
signaling in CMs , which is linked to cAMP signaling, was en-
riched specifically in cluster 5 (upregulated in CMECFs and
CMEC ACFs; Figure 3F). scRNA-seq also revealed enrichment
of the KEGG term for the pathway ‘‘adrenergic signaling in
CMs’’ among genes that were upregulated in CMs in CMECFs
versus 2D CMs (Table S2). Among these, the CM-specific ad-
enylyl cyclase isoform ACDY5 was significantly upregulated in
CMs from CMECFs versus 2D CMs (Log2FC = 1.78; PFDR <
0.05; Table S2). This prompted us to examine whether the up-
stream regulators of ADCY5 were also elevated in CMs in MTs.
CMs in MTs showed higher expression of the endothelin-1
(EDN1) receptor ENDRA, which is responsible for induction of
ATF3 expression that in turn would induce expression of EGR1
(Giraldo et al., 2012), a core transcription factor involved in upre-
gulation of adrenergic receptors (ADRB1 and ADRB2; Iwaki
et al., 1990) and ADCY5 itself (Table S2). Besides adenylyl
cyclase, we also found that the soluble guanylyl cyclase isoform
GUCY1A3 was upregulated in CMs and CFs in MTs and highly
expressed in CFs compared to CMs in MTs (Log2FC = 2.37;
PFDR < 0.05; Table S5). GUCY1A3 is specifically expressed in
CFs and not SFs based on published datasets (Furtado et al.,
2014). We therefore hypothesized the mechanism illustrated in
Figure 6A, proposing that CFs act as a source of cyclic guano-
sine monophosphate (cGMP) that is shuttled to the CMs via
gap junctions and inhibits activity of the phosphodiesterases
(PDEs) that convert cAMP to AMP. This might indirectly regulate
cAMP levels in CMs. In linewith this, MTs showed higher levels of
cAMP in CMECFs and CMEC SFs compared to CMECs (Fig-
ure S6A). Our scRNA-seq data also supported evidence for the
importance of ECs in CM maturation in our MT model, as ECs
are the major source of EDN1 and nitric oxide (NO) (generated
by EC-specific NOS3), which could activate ADNRA and
GUCY1A3 in CMs and CFs (Figure 6B). Importantly, MTs without(B) Traces (left) and bar graphs (right) for oxidative phosphorylation (oxygen cons
(C) Traces (left) and bar graphs (right) for glycolytic acidification (extracellular aci
**p < 0.01; ***p < 0.001. All data are shown as mean ± SEM. N indicates MTs fro
multiple comparison test is shown.ECs do not express EDN1 and NOS3 (Figure S6B). Bulk RNA-
seq also suggested that CMECFs had higher expression of
ADCY5 than CMEC SFs and GUCY1A3 was significantly higher
in CMECFs than CMEC SFs (Figure 6C).
In clusters 3 and 6, GO analysis showed enrichment for the
terms ‘‘extracellular matrix organization’’ and ‘‘cell junction as-
sembly’’ (Figure 3E). Importantly, expression of CX43 (GJA1)
was highly upregulated in scRNA-seq in CMs from CMECFs
versus 2D CMs (Log2FC = 1.9; PFDR < 0.05; Table S2). CFs
dissociated from CMECFs had well-formed CX43 gap junctions
with CMs although, by contrast, SFs even in close contact with
CMs did not interact via gap junctions (Figure 6D). We therefore
hypothesized that CFs coupling to CMs via CX43-mediated gap
junctions could promote CM maturation, possibly also via
cGMP-cAMP pathways, as described above, further enhancing
gap junctions in CMs (Figure 6A).
To test the effect of cAMP levels in CMs, we added its soluble
form, dibutyryl cAMP (dbcAMP), to hiPSC-CMs. The resting
membrane potential became more negative, the AP amplitude
and upstroke velocity higher, and contraction velocity and accel-
eration faster (Figure 6E), suggesting that persistent activation of
the cAMP pathway could contribute to hiPSC-CM maturation.
We investigated this further as follows: (1) we tested whether
CMEC SFs could be ‘‘rescued’’ by adding dbcAMP to elevate
cAMP levels. This showed hiPSC-CMs in CMEC SFs had better
organized and longer sarcomeres, much like those in CMECFs,
but there was no further structural maturation in CMECFs with
dbcAMP (Figures 6F, 6H, 6I, S6F, and S6G); (2) we tested
whether maturation in CMEC SFs could be rescued by ectopic
overexpression of CX43 in SFs prior to incorporation in MTs
with control hiPSC-CMs and hiPSC-ECs (CMEC SFs CX43 LV;
Figures 6G and S6C). Although CX43 was upregulated (Figures
S6E and S6H), sarcomeres in CMEC SFs CX43 LV were less
organized and shorter than either CMECFs or CMEC SFs with
dbcAMP (Figures 6H, 6I, S6F, and S6G). Of note, although
CX43 was mainly localized at the cell-cell contacts in CMECFs,
it was largely confined to the cytoplasm in CMEC SFs and
CMECSFsCX43 LV. This suggests that proper CX43 localization
is important to enhance sarcomere organization (Figures 6F, 6G,
S6D, and S6E). Furthermore, overexpression of CX43 in SFs did
not rescue contraction in CMEC SFs (Figure S6I); (3) we silenced
CX43 in hiPSC-CFs using short hairpin RNA (shRNA) (Figures
S6J and S6K) and incorporated these into MTs with control
hiPSC-CMs and hiPSC-ECs (siCX43-CMECFs; Figure 6J). Sar-
comeres in siCX43-CMECFs were less organized and shorter
than CMECFs based on IF (Figures 6L and 6M) and TEM (Figures
6K–6N). Contraction duration was also reduced in siCX43-
CMECFs compared to CMECFs, although inter-beat intervals
were unaltered (Figure 6O).
Taken together, this demonstrated roles for the cAMP
pathway and CX43 in the tri-cellular interactions inducing
CM maturation in MTs. These experiments also suggested that
there may also be additional mechanistic components missing
in SFs, including, for example, GUCY1A3; despite CX43umption rate, OCR) from Seahorse measurements in MTs. n > 52; ***p < 0.001.
dification rate, ECAR) from Seahorse measurements in MTs. n > 44; *p < 0.05;
m 3–5 independent batches per group. One-way ANOVA with Games-Howell
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Figure 6. Mechanisms Underlying hiPSC-CM Maturation in Microtissues with CFs and ECs
(A) Proposed mechanism underlying hiPSC-CM maturation in MTs with CFs and ECs: ECs (green) secrete EDN1 that activates b-adrenergic signaling and
adenylyl cyclase in CMs (red), increasing intracellular cAMP levels, which can enhance CX43 gap junction formation. ECs also secrete NO that activates cGMP
pathway in CFs (blue). cGMP can shuttle to CMs via gap junctions (dotted blue arrow), sustaining cAMP in CMs.
(legend continued on next page)
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component of MTs.
Microtissues Enable Multilineage Cardiac Disease
Modeling
CMs are the only affected cells in channelopathies, but other in-
herited cardiac disorders may not be CM autonomous, with non-
myocyte cells in the heart playing active etiological roles in the dis-
ease (Blazeski et al., 2019; Sommariva et al., 2017). Arrhythmo-
genic cardiomyopathy (ACM) is one such rare genetic disorder,
predominantly associated with mutations in desmosomal genes
and characterized by arrhythmias and fibro-fatty replacement of
the myocardium (Lazzarini et al., 2015; Sommariva et al., 2017).
A role forCFs inACMpathophysiologyhasbeen recently indicated
using primary cells from patients (Sommariva et al., 2016). Here,
we used ACM hiPSCs from a patient carrying the heterozygous
c.2013delC PKP2 mutation, which results in a premature stop
codon (Figure 7A). We generated CTRL- and ACM-MTs by
combining CTRL hiPSC-CMs and ECs with either CTRL hiPSC-
CFs or SFs or with ACM hiPSC-CFs or SFs (Figure 7B). Although
no differences in morphology (Figure 7C) or epicardial (ZO-1,
WT1, and TBX18) and fibroblast (COL1A1) marker expression
were detected in hiPSC-ACM-EPIs and ACM-CFs compared
with controls (Figures S7A–S7C), ACM-EPIs showed lower PKP2
levels by western blot (Figure 7D) and reduced PKP2 at cell junc-
tions by IF (Figures S7DandS7E), likely due to thePKP2mutation.
Interestingly, thiswas paralleled by reduced junctional localization
of CX43 in ACM-EPIs (Figures S7D and S7E), in agreement with a
role of PKP2 in regulating CX43 trafficking (Agullo-Pascual et al.,
2013; Oxford et al., 2007; Sato et al., 2011; Zhang and Shaw,
2014). PKP2 protein expression in hiPSC-CFs was much lower
than in hiPSC-EPIs, in agreement with absence of desmosomes
in CFs and differences between ACM- and CTRL-CFs were less
clearly detected (Figure 7D). Nevertheless, in MTs, we found that
CTRL CFs, but not ACM CFs, sustained CX43 expression
throughout the microtissue (Figures 7E, 7F, and S7J), although
sarcomere organization was not affected in CMs (Figure S7K).
Furthermore,MTswith CTRL or ACMSFs did not show any differ-
ences in CX43 expression (Figures 7E–7G).(B) Violin plots showing (log-transformed) expression of NOS3, EDN1, EDNRA, E
(C) Heatmap showing selected gene expression from bulk RNA-seq of CMECFs
(D) Immunofluorescence analysis of CX43 (green) and ACTN2 (red) in hiPSC-CMs
indicate coupling between hiPSC-CFs and hiPSC-CMs. SFs do not couple with
(E) Representative AP traces of untreated (CTRL, black) and 72-h-dbcAMP-treat
contraction velocity, and acceleration. n > 10; dissociated cells per group; *p < 0
(F and G) Representative immunofluorescence images of CX43 (green) and ACTN
treated for 7 days with dbcAMP (CMECFs +dbcAMP, CMEC SFs +dbcAMP; F
lentivirus (LV) (CMEC SFs empty LV) or lentivirus containing CX43 LV (CMEC SFs
magnifications of framed areas to show CX43 distribution.
(H and I) Sarcomere organization (sarcomere alignment index; H) and sarcomere le
areas from 3 MTs per group; **p < 0.05; ***p < 0.005; ****p < 0.0001. Data are me
(J) Representative immunofluorescence images of cardiac sarcomeric proteins
containing either untreated hiPSC-CFs (CMECFs) or hiPSC-CFs transduced wit
bar: 10 mm.
(K) TEM showing sarcomeres in CMECFs and siCX43-CMECFs. Scale bar: 0.5 m
(L–N) Quantification of sarcomere organization (sarcomere alignment index; L) and
from 4MTs per group; *p < 0.05) and of sarcomere length inMTs from TEM (-n; n >
as mean ± SEM. Student’s t test is shown.
(O) Contraction duration (left) and IBI (right) measured in spontaneously beating M
test is shown. Data are shown as mean ± SEM.Wenext characterized the electrical properties ofMTs by stim-
ulating them at increasing pacing frequencies. Inclusion of ACM
hiPSC-CFs significantly reduced the ability of MTs to respond to
high stimulation frequencies (R2 Hz), which resulted in
arrhythmic behavior (Figures 7H and 7I). Arrhythmic behavior
can be linked to failure of CMs to properly couple, possibly
because of reduced CX43 expression. Of note, this arrhythmic
ACM phenotype was not captured in MTs with SFs.
Finally, we noted a higher proportion of cells positive for alpha-
smooth muscle actin (SMA) in ACM-EPIs (Figures S7F and S7G)
and CFs compared to controls (Figures S7H and S7I). This sug-
gested that (1) ACM EPIs had a higher propensity to undergo
epithelial-to-mesenchymal transition (EMT), supporting the
concept that epicardial cells are a source of fibro-fatty substitu-
tion in the hearts of ACM patients with PKP2 mutations (Lom-
bardi et al., 2009; Matthes et al., 2011) and (2) some ACM-CFs
display a myo-fibroblast-like phenotype, which may impact con-
duction of CMs in MTs (Thompson et al., 2011).
Taken together, these findings provide evidence of non-myo-
cyte contributions to ACM pathogenesis and demonstrate the
utility of MTs that are completely hiPSC derived in modeling dis-
eases not autonomous to CMs.
DISCUSSION
In this study, we described a 3D MT system composed of CMs ,
cardiac ECs , and CFs, the three major cell types of the heart,
derived entirely from hiPSCs. MTs were formed from just 5,000
cells by self-aggregation in controlled ratios that remained con-
stant over time. Tri-cellular crosstalk promoted hiPSC-CMmatu-
ration specific to CFs. This required close cellular contacts and
CX43 gap junctions. In contrast to other 3D systems, such as
EHTs (Lemoine et al., 2017; Mannhardt et al., 2016; Ronald-
son-Bouchard et al., 2018; Tiburcy et al., 2017), MTs enhanced
CM maturation without requiring specialized devices and anal-
ysis tools, technical tissue engineering expertise, mechanical
load, scaffolds, or complex substrates. The three cardiac cell
types for MTs can be derived isogenically from the same
hiPSC-derived cardiac mesoderm, in a highly reproducible wayGR1, ADCY5, and GUCY1A3 in CMECFs based on scRNA-seq.
and CMEC SFs.
and fibroblasts dissociated from CMECFs and CMEC SFs MTs. White arrows
hiPSC-CMs. Nuclei are stained with DAPI (blue). Scale bar: 50 mm.
ed (dbcAMP, gray) CTRL1 hiPSC-CMs, with quantification of RMP, APA, Vmax,
.001. Data are mean ± SEM. Student’s t test is shown.
2 (red) in MTs from CTRL1 hiPSCs, either untreated (CMECFs, CMEC SFs) or
) and MTs from CTRL1 hiPSC containing either SFs transduced with control
CX43 LV; G). Nuclei are stained with DAPI (blue). Scale bar: 10 mm. Insets are
ngth (I) from immunofluorescence analysis of MTs fromCTRL1 hiPSCs. n = 30;
an ± SEM. One-way ANOVA with Tukey’s multiple comparisons test is shown.
ACTN2 (red) and TNNI (green) in CMECFs generated from CTRL1 CMECFs
h CX43-shRNA (siCX43-CMECFs). Nuclei are stained with DAPI (blue). Scale
m.
sarcomere length (M) from immunofluorescence analysis in MTs (n = 60; areas
117; areas from 3 independent stitches per group; *p < 0.0001). Data are shown
Ts. n > 40; MTs from 3 independent batches per group; *p < 0.05. Student’s t
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Figure 7. Microtissues as a Model of Arrhythmogenic Cardiomyopathy (ACM)
(A) Sequencing ofPKP2 gene showing heterozygous c.2013delC (p.K672RfsX12) mutation in exon 10 in ACMhiPSCs.PKP2 sequence of CTRL1 hiPSCs is shown
as reference.
(legend continued on next page)
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altering their properties. MT construction was robust and highly
reproducible with low sample-to-sample, batch-to-batch, and
line-to-line variability across multiple parameters. The results
demonstrated our in vitro cardiac tissue model is low cost
(±0.22V per MT); amenable to high-throughput production for
structural, functional, and electrophysiological analysis; and
illustrated the utility of MTs in disease modeling.
Postnatal CMs have longer and more organized sarcomeric
structures than fetal and hiPSC-CMs, and these ensure
proper force generation. After birth, T-tubules mediate rapid
excitation-contraction coupling, electrophysiological properties
change due to expression of distinct ion channels, conduction
velocities are higher due to subcellular redistribution of CX43
gap junction protein, there are greater intracellular Ca2+ stores,
ryanodine receptors mediate Ca2+ release, and metabolism is
dependent on fatty acid oxidation rather than glycolysis (Yang
et al., 2014). Here, we showed that many of these features
were evident hiPSC-CMs in tri-cellular MTs and CFs outper-
formed primary SFs. Specifically CMECFs showed improve-
ments in (1) structure: sarcomere length and organization were
increased, with ultrastructure characteristics of mature CMs (H
zones, I-bands, M-lines, T-tubule-like structures, and elongated
mitochondria adjacent to sarcomeres); (2) function: mechanical
contraction (increased duration and amplitude) and Ca2+
handling were improved and electrophysiology showed more
mature AP profiles (hyperpolarized RMP and higher upstroke ve-
locity); and (3) metabolism: mitochondrial respiration capacity
was increased although dependence on glycolysis was
decreased. Importantly, this broad spectrum of maturation fea-
tures was only achieved in MTs containing both hiPSC-ECs
and CFs (either adult or hiPSC derived), indicating that the tri-
cellular crosstalk is essential.
RNA-seq analysis showed that cAMP/b-adrenergic and cell
junction assembly pathways were specifically upregulated in
CMECFs, but not in MTs with non-cardiac fibroblasts, suggest-
ing their involvement in enhancing maturation. Notably, cAMP
levels were higher in CMECFs and dbcAMP increased electri-
cal maturation in hiPSC-CMs even in 2D. Based on our results
and published data on signaling in the heart, we propose that
one mechanism underlying enhanced maturation in MTs (Fig-
ure 6A) involves both ECs and CFs, with increased cAMP levels
in CMs positively affecting the assembly of CX43 gap junctions.
This notion is supported by our data showing sustained cAMP
signaling through exogenous dbcAMP also improved sarco-
meric organization in CMEC SFs to the level of CMECFs.(B) Generation of CTRL and ACM MTs using CTRL hiPSC-CMs and CTRL hiPSC
SFs. Cell percentages (black) and numbers (gray) are indicated at the top.
(C) Representative bright-field images of CTRL- and ACM-CFs. Scale bar: 100 m
(D) Western blot for PKP2 in CTRL and ACM hiPSC-EPIs and CFs. CTRL-EPIs we
samples are two independent differentiations from ACM hiPSCs. CTRL and ACM
ACM hiPSCs, respectively. GAPDH was used as loading control. Densitometric
(E) Immunofluorescence analysis of CX43 (green) in CTRL CMECFs, ACM CMEC
(blue). Scale bar: 25 mm.
(F and G) Quantification of CX43 per cell in CTRL and ACM CMECFs (F) and in C
0.005). Data are shown as mean ± SEM, normalized to the respective CTRL. Stu
(H) Representative contraction traces from CTRL and ACM CMECFs and CTRL
(I) Percentages of MTs that could be paced at different stimulation frequencies in
shown as mean ± SEM. Chi-square test is shown. All data shown were from CTRInvolvement of gap junctions was demonstrated by silencing
CX43 in CMECFs using shRNA, which reduced structural orga-
nization of sarcomeres. Lack of CX43 in CMECFs also reduced
contraction duration but did not affect the beating rate, sug-
gesting that the faster beating rate in CMECFs was not neces-
sary or sufficient for structural maturation but also that CX43
was not required for maintaining the beating rate. CX43 expres-
sion as such did not appear to be the sole mechanism for
maturation, however, because CX43 overexpression in CMEC
SFs only partially rescued structural organization compared
to CMECFs or dbcAMP treatment. Of note, CX43 overexpres-
sion in SFs resulted mostly in cytoplasmic rather than cell junc-
tion CX43 localization. Thus, we identified some key mecha-
nisms in the tri-cellular interactions that enhance CM
maturation, but other mechanisms, such as cell-extracellular
matrix interactions or paracrine effects, may also play roles.
These will likely all be necessary ultimately to obtain fully
mature hiPSC-CMs.
One important advantage of our tri-cellular MT system based
entirely on hiPSC-derived cells is the opportunity to create pa-
tient-specific models of disease that may have multicell-type
causes. This was illustrated by our use of hiPSC-CFs derived
from an ACM patient carrying a PKP2 mutation. When incorpo-
rated into MTs as the only diseased cellular component, ACM-
CFs induced arrhythmic behavior in wild-type (WT) CMs. Of
note, ACM-CFs were characterized by a higher tendency to as-
sume a myofibroblast-like identity and ACM-MTs showed
reduced CX43 expression. Both features could impact electrical
conduction of CMs. Arrhythmia is one of the earliest events in
ACM patients, preceding fibro-fatty deposition (Gomes et al.,
2012); thus, our data showed another role of CFs in ACM patho-
genesis. This experiment demonstrates the utility of the MT sys-
tem in modeling multicellular cardiac disease, as it enabled
investigation of interactions among cell types, specifically iden-
tification of cellular ‘‘culprits’’ versus ‘‘victims’’ in diseases non-
autonomous to CMs.
In conclusion, 3D models of the heart based on hiPSCs are
already excellent resources to study differentiation of human
heart cells in development and the consequences of heart
disease or drugs in vitro. The incorporation of multiple cardiac
cell types as here serves as an exemplar for MTs of other
organs for which either biopsies are not feasible or there is a
stromal component to the disease not captured by only
including one cell type in a bioassay in vitro. We have illustrated
the power of being able to create cells from patient-specific
lines. As large-scale studies on genetics and corresponding-ECs combined with either CTRL or ACM hiPSC-CFs or primary CTRL or ACM
m.
re differentiated from two hiPSC lines (CTRL1 and CTRL2), although ACM EPI
CF samples are two and three independent differentiations from CTRL1 and
analysis is shown in the lower panel.
Fs, CTRL CMEC SFs, and ACM CMEC SFs MTs. Nuclei are stained with DAPI
TRL and ACM CMEC SFs (G; n = 3; independent MT batches per group; **p <
dent’s t test is shown.
and ACM CMEC SFs stimulated at 1 Hz, 2 Hz, and 3 Hz.
different MT groups (see legend). n > 10; MTs per group; *p < 0.05. Data are
L1 and/or CTRL2 hiPSC as a source of hiPSC-CMs, CFs, and primary SFs.
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US; and CiRA, Japan), this will yield more ‘‘variants of unknown
significance,’’ many of which will not only be expressed by
CMs. Environmental diseases, such as fibrosis following
myocardial infarction and microvascular disease leading to
heart failure with preserved ejection fraction, are also
multicellular.
Controlled formation of hiPSC-derived MTs with the major cell
types of the heart thus represents a valuable platform that regu-
latory authorities, pharmaceutical companies, and academia
can use to understand multicellular heart conditions, identify
therapeutic targets, and predict drug efficacy in humans.STAR+METHODS
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Antibodies
Anti-Troponin I antibody (H-170) (TNNI) for
immunofluorescence (1:500)
Santa Cruz Biotechnology Cat# sc-15368; RRID:AB_793465
Anti-alpha-Actinin (Sarcomeric) antibody
(ACTN2) for immunofluorescence (1:800)
Sigma–Aldrich Cat# A7811; RRID:AB_476766
Anti-CD31/PECAM-1 antibody for
immunofluorescence (1:200)
R&D Systems Cat# AF806; RRID:AB_355617
Anti-Collagen Type I, clone 5D8-G9 antibody
(COL1A1) for immunofluorescence (1:200)
Millipore Cat# MAB3391; RRID:AB_94839
Anti-Wilm’s Tumor Protein antibody (WT1) for
immunofluorescence (1:200)
Millipore Cat# CA1026-50UL; RRID:AB_437848
Anti-TBX18 antibody (TBX18(for
immunofluorescence (1:200)
Sigma-Aldrich Cat# HPA029014; RRID:AB_10601597
Anti-ZO-1 antibody (ZO-1) for
immunofluorescence (1:200)
Thermo Fisher Scientific Cat# 61-7300; RRID:AB_2533938
Anti-Ki67 Antibody (Ki67) for
immunofluorescence (1:200)
Abcam Cat# ab833; RRID:AB_306483
Anti-Connexin 43/GJA1 antibody (CX43) for
immunofluorescence (1:200)
Abcam Cat# ab11370; RRID:AB_297976
Anti-alpha-Smooth Muscle Actin, Clone 1A4
antibody (aSMA) for
immunofluorescence (1:200)
Sigma-Aldrich Cat# A2547; RRID:AB_476701
Anti-Plakophilin 2, clone 518 antibody (PKP2)
for immunofluorescence (1:25)
Progen Cat# 651157
Cy3-AffiniPure Donkey Anti-Mouse IgG (H+L)
antibody for immunofluorescence (1:100)
Jackson ImmunoResearch Labs Cat# 715-165-150; RRID:AB_2340813
Donkey anti-Rabbit IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 488
for immunofluorescence (1:200)
Thermo Fisher Scientific Cat# A-21206; RRID:AB_2535792
Donkey anti-Mouse IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody, Alexa Fluor 594
for immunofluorescence (1:200)
Thermo Fisher Scientific Cat# A-21203; RRID:AB_2535789
Donkey Anti-Sheep IgG (H+L) Antibody, Alexa
Fluor 647 for immunofluorescence (1:200)
Thermo Fisher Scientific Cat# A21448; RRID:AB_10374882
Anti-Plakophilin 2, Clone 28 antibody (PKP2) for
western blot (1:1000)
BD Biosciences Cat# 610788; RRID:AB_398109
Anti-Glyceraldehyde-3-PDH antibody (GAPDH)
for western blot (1:2000)
Millipore Cat# MAB374; RRID:AB_2107445
Anti-mouse IgG, HRP-linked antibody for
western blot (1:2000)
Cell Signaling Technology Cat# 7076; RRID:AB_330924
Bacterial and Virus Strains
Lentivirus expressing short hairpin RNA
(shRNA) targeting Cx43
Sigma Aldrich TRCN0000059773
Lentivirus expressing Cx43 (LV.hCMV-
IE.HsGJA1.IRES.PurR.hHBVPRE)
Liu et al., 2018 PMID: 29917042 N/A
Empty vector (LV.hCMV-
IE.IRES.PurR.hHBVPRE)
Liu et al., 2018 PMID: 29917042 N/A
Chemicals, Peptides, and Recombinant Proteins
Essential 8 Medium Thermo Fisher Scientific A1517001
Matrigel hESC-Qualified Matrix Corning 354277
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Vitronectin, truncated recombinant human
(VTN-N)
Thermo Fisher Scientific A14700
Fibronectin bovine plasma Sigma Aldrich F1141
RevitaCell Supplement (100X) Thermo Fisher Scientific A2644501
UltraPure 0.5 M EDTA, pH 8.0 Thermo Fisher Scientific 15575020
TrypLE Select, 10x Thermo Fisher Scientific A1217701
Recombinant Human BMP-4 Protein R&D Systems 314-BP
Human Activin A, premium grade Miltenyi Biotec 130-115-010
CHIR 99021 Axon Medchem Axon1386
XAV939 Tocris 3748/10
Human VEGF, premium grade Miltenyi Biotec 130-109-386
Retinoic Acid Sigma Aldrich R2625
TGFb inhibitor, SB431542 Tocris 1614/10
Human FGF-2, premium grade Miltenyi Biotec 130-093-842
Fibroblast Growth Medium 3 PromoCell C-23025
CryoStor CS10 medium Stem Cell Technologies 07930
Puromycin dihydrochloride Sigma Aldrich P7255
Polybrene Sigma Aldrich H9268
Collagenase type II Worthington LS004176
Fluo-4, AM, cell permeant Thermo Fisher Scientific F14201
Tissue-Tek OCT Sakura Finetek 4583
Verapamil hydrochloride Tocris 0654
Bay-K8644 Tocris 1544
Caffeine Sigma Aldrich C0750
Dibutyryl cyclic-AMP (dbcAMP) Sigma Aldrich D0627
Oligomycin Sigma Aldrich O4876
Carbonyl cyanide 4-(trifluoromethoxy)
phenylhydrazone (FCCP)
Sigma Aldrich C2920
Antimycin A Sigma Aldrich A8674
Rotenone Sigma Aldrich R8875
2-Deoxy-D-glucose (2-DG) Sigma Aldrich D8375
Critical Commercial Assays
EasySep Human CD34 Positive Selection Kit II Stem Cell Technologies 17856
Multi Tissue Dissociation Kit 3 Miltenyi Biotec 130-110-204
Quant-iT PicoGreen dsDNA Assay Kit Thermo Fisher Scientific P7589
Direct cAMP ELISA kit Enzo Life Sciences ADI-900-066
NucleoSpin RNA Kit Macherey- Nagel 740955
iScript-cDNA Synthesis kit Bio-Rad 170-8889
iTaq Universal SYBR Green Supermix Bio-Rad 1725124
BCA Protein Assay Kit Thermo Fisher Scientific 23227
SupersignalWest Dura Extended Duration
Substrate
Thermo Fisher Scientific 37071
Deposited Data
Gene expression (bulk RNA-sequencing) This paper GEO: GSE116464
Gene expression (single-cell RNA-sequencing) This paper GEO: GSE147694
Experimental Models: Cell Lines
CTRL1 hiPSC line LUMC hiPSC core facility LUMC0020iCTRL-06 https://hpscreg.
eu/cell-line/LUMCi028-A Zhang et al.,
2014 PMID: 25453094
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CTRL2 hiPSC line LUMC hiPSC core facility LUMC0099iCTRL04 https://hpscreg.
eu/cell-line/LUMCi004-A
CTRL3 hiPSC line LUMC hiPSC core facility LUMC0059iCTRL03
CTRL hiPSC line NCRM1 NIH Center for Regenerative Medicine NIH
CRM, obtained from RUDCR Infinite Biologics
at Rutgers University
(Guadix et al., 2017) PMID: 29173898
LQT1 hiPSC line Zhang et al., 2014 PMID: 25453094 LUMC0021iKCNQ-30 Zhang et al.,
2014 PMID: 25453094
ACM hiPSC line This study LUMC0153iPKP
CTRL1 SFs LUMC hiPSC core facility WK12220
CTRL2 SFs LUMC hiPSC core facility WK12022
ACM SFs Monzino Hospital, Milan WK13262
Human adult cardiac fibroblasts PromoCell C-12375
Software and Algorithms
Fiji-ImageJ Schindelin et al., 2012 PMID: 22743772 https://imagej.net/Fiji/Downloads
CellProfiler Carpenter et al., 2006 PMID: 17076895 https://cellprofiler.org
IMARIS Oxfornd Instruments N/A
MATLAB Mathworks Inc N/A
Aperio ImageScope Leica N/A
GraphPad Prism 8.2.0 GraphPad N/A
MUSCLEMOTION Sala et al., 2018 PMID: 29282212 https://www.ahajournals.org/doi/
suppl/10.1161/CIRCRESAHA.117.
312067
RStudio RStudio https://rstudio.com/products/rstudio
Origin 2016 OriginLab N/A
Clampex 10.0 Molecular Devices Axon Instruments N/A
LabVIEW National Instruments N/A
LUMC BIOPET Gentrap LUMC Sequencing Analysis Support Core https://github.com/biopet/biopet
Python Python Software Foundation https://www.python.org
Image Lab Bio-Rad N/A
ll
OPEN ACCESS ArticleRESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Prof.
Christine L. Mummery (C.L.Mummery@lumc.nl).
Materials Availability
hiPSC lines are available upon MTA.
Data and Code Availability
The accession numbers for the bulk and single cell RNA sequencing datasets reported in this paper are https://www.ncbi.nlm.nih.
gov/geo/ GEO: GSE116464 (bulk) and GEO: GSE147694 (single cell). Software used to analyze the data are either freely or commer-
cially available. Motion Flow analysis software can be requested by contacting L.G.J.Tertoolen@lumc.nl.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Ethics statement
Protocols for research involving human subjects and stem cell research were approved by the medical ethical committee at Leiden
University Medical Center, the Netherlands and Centro Cardiologico Monzino, Milan, Italy. Written informed consent was received
from participants prior to inclusion in the study.e3 Cell Stem Cell 26, 862–879.e1–e11, June 4, 2020
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CTRL1 hiPSC line LUMC0020iCTRL-06 (female, Giacomelli et al., 2017a, 2017b; Zhang et al., 2014), CTRL2 hiPSC line LUM-
C0099iCTRL04 (female), CTRL3 hiPSC line LUMC0059iCTRL03 (female), LQT1 hiPSC line LUMC0021iKCNQ-30 (female, Zhang
et al., 2014) and ACMhiPSC line LUMC0153iPKP (female, see below formutation) were generated from primary skin fibroblasts using
Sendai virus by the LUMC hiPSC core facility. CTRL hiPSC line NCRM1 (NIH Center for Regenerative Medicine NIH CRM) was ob-
tained from RUDCR Infinite Biologics at Rutgers University. All the hiPSC lines used in this study were assessed for pluripotency and
routinely tested for mycoplasma and genomic integrity by karyotyping. All hiPSC lines were seeded on vitronectin recombinant hu-
man protein and cultured in E8 medium as described previously (Giacomelli et al., 2017a, 2017b). Cells were passaged twice a week
using PBS containing EDTA 0.5 mM. RevitaCell Supplement (1:200) was added during passaging (all from Thermo Fisher Scientific).
Clinical history and genetic phenotype of ACM patient
A 37 years old woman presented with inverted T waves V1-V2 on the ECG but was without dysfunctional and structural alterations at
echocardiography and magnetic resonance imaging (MRI). Family history indicated sudden cardiac death in the family (mother and
maternal uncle died suddenly in their thirties) and a brother was clinically affected by ACM. Sequencing of the PKP2 gene (GenBank:
NM_004572.3) identified the heterozygous c.2013delC mutation in exon 10, which causes a frameshift (p.Lys672fs) and premature
termination in exon 10 (Figure 7A) in the brother and the patient. Two years later, the patient developed frequent premature ventricular
contraction and was hospitalized for further medical assessment and possibly loop recorder implant. ECG showed repolarization
(inverted T waves V1-V2), depolarization, and conduction (ε wave) abnormalities and MRI documented mild right ventricle enlarge-
ment. Endomyocardial biopsy at this stage showed a limited area of fibro-fatty substitution and inflammatory cells, and another area
mostly composed of adipose tissue (not shown).
Primary fibroblasts culture
Human adult cardiac fibroblasts (ACFs; PromoCell) were cultured in FGM3 (PromoCell) medium following themanufacturer’s instruc-
tions; human adult skin fibroblasts (CTRL1 SFs WK12220, CTRL2 SFs WK12022 from Leiden University Medical Center hiPSC core
facility, ACM SFs WK13262, from Monzino Hospital, Milan) were cultured in DMEM/F12 Glutamax medium supplemented with 10%
FBS, 1% Non-essential amino acids (NEAA), 1% penicillin/streptomycin (pen/strep) and 0.18% 2-mercaptoethanol (all from Thermo
Fisher Scientific). Cell dissociation was carried out using TrypLE 1X for 5 min at 37C, 5%CO2, followed by centrifugation for 3 min at
1100 rpm and resuspension either in FGM3 medium (ACFs) or DMEM/F12 supplemented medium (SFs). Fibroblasts (10cm2 per vial)
were cryopreserved in CryoStor CS10 medium (0.5ml/vial; Stem Cell Technologies).
Human fetal heart ECs and fibroblasts
RNA from human fetal heart ECs and fibroblasts was isolated at passage 1 (P1) after collection from fetal heart samples at gestation
ages Week(W)12.5, W15 and W21. Human fetal tissue samples were obtained from elective abortion material (vacuum aspiration)
without medical indication through approval to Dr Chuva de Sousa Lopes by the Medical Ethical Committee of Leiden Medical Uni-
versity Center (P08.087). Informed consent was obtained and the studywas conducted in accordancewith the Declaration of Helsinki
by the World Medical Association.
METHOD DETAILS
Differentiation of hiPSCs into CMs, cardiac ECs and EPI
CM differentiation was induced in monolayer as described previously (Giacomelli et al., 2017a, 2017b; van den Berg et al., 2016).
Briefly, 253 103 cells per cm2 (CTRL1, CTRL2, CTRL3) were seeded on plates coated with 75 mg/ml growth factor-reduced Matrigel
(Corning) the day before differentiation (day1). On day 0, cardiac mesodermwas induced by changing E8 to BPELmedium (Bovine
Serum Albumin [BSA] Polyvinyl alcohol Essential Lipids (Ng et al., 2008), supplemented with a mixture of cytokines (20 ng/ml BMP4,
R&DSystems; 20 ng/ml ACTIVIN A,Miltenyi Biotec; 1.5 mMGSK3 inhibitor CHIR99021, AxonMedchem). After 3 days, cytokineswere
removed and the Wnt inhibitor XAV939 (5 mM, Tocris) was added for 3 days. BPEL medium was refreshed every 3 days. Cardiac EC
differentiation was induced in monolayer as described previously (Giacomelli et al., 2017a, 2017b). Briefly, 15 3 103 cells per cm2
(CTRL1, CTRL2) were seeded on Matrigel at day 1. On day 0, cardiac mesoderm was induced as described above. On day 3, cy-
tokines were removed and VEGF (50 ng/ml, R&D Systems) added with XAV939 (5 mM). Cardiac ECs were isolated as described pre-
viously (Giacomelli et al., 2017a, 2017b) using a Human cord blood CD34 Positive selection kit II (StemCell Technologies) following
the manufacturer’s instructions. For cardiac ECs culture, 153 103 cells per cm2 cells were seeded on fibronectin-coated plates and
cultured in BPEL medium supplemented with VEGF (50ng/ml). After 3-4 days, cells were confluent and cells (30cm2 per vial) were
cryopreserved in CryoStor CS10 medium (0.5ml per vial; StemCell Technologies). EPI differentiation was induced in monolayer
as described previously (Guadix et al., 2017). Briefly, 25 3 103 cells per cm2 (CTRL1, CTRL2, CTRL4) and 30 3 103 per cm2
(LQT1, ACM) were seeded on Matrigel at day 1. On day 0, cardiac mesoderm was induced as described above. After 3 days, cy-
tokines were removed and the WNT inhibitor XAV939 (5 mM) added for 3 days with BMP4 (30 ng/ml) and Retinoic Acid (RA; 1 mM;
Sigma Aldrich). On day 6, BPEL medium supplemented with BMP4 (30 ng/ml) and RA (1 mM) was refreshed. On day 9, 15 3 103
per cm2 (CTRL1, CTRL2, CTRL4) and 20 3 103 per cm2 (LQT1, ACM) were seeded on plates coated with 2-5 mg/ml of fibronectin
from bovine plasma (fibronectin; Sigma Aldrich) in BPEL medium supplemented with the TGFb inhibitor SB431542 (10 mM; Tocris).Cell Stem Cell 26, 862–879.e1–e11, June 4, 2020 e4
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medium (0.5 ml/vial; Stem Cell Technologies).
Differentiation of hiPSC-EPI into CFs
CF differentiation was induced in monolayer, similarly to Zhao et al. (2017). Briefly, 253 103 EPI (CTRL1, CTRL2, CTRL4 LQT1, ACM)
were seeded per cm2 on tissue culture plates coated with vitronectin in BPELmedium supplemented with FGF2 (10 ng/ml; R&D Sys-
tems) on day 12. On day 13 and every 2 days thereafter, mediumwas refreshed with BPEL supplemented with FGF2 (10 ng/ml). After
6 days (on day 19), CFs were expanded by changing BPEL to Fibroblast Growth Medium 3 (FGM3; PromoCell). FGM3 was refreshed
every 2 days for approximately 10 days in total. After 10 days (on day 29), CFs were confluent and ready to be passaged at 1:2 ratio.
FGM3was refreshed the day after passaging and every 2 days thereafter. CFs (10cm2 per vial) were cryopreserved in CryoStor CS10
medium (0.5ml/vial; Stem Cell Technologies).
Lentiviral transduction of hiPSC-CFs using shRNA-CX43
Lentivirus expressing short hairpin RNA (shRNA) targeting Cx43 (Sigma, TRCN0000059773) was used to downregulate Cx43 in
CTRL1 hiPSC-CFs (Cx43-sh-RNA CFs). Briefly, one day after seeding 60000 cells/12-well, hiPSC-CFs were transduced with viral
particles at MOI 1 in fresh FGM3 with 8 mg/mL polybrene overnight. GFP expressing virus (pLV-CMV-GFP) was used as a control
(scramble shRNA). 72 h post-transduction, when control cells expressed GFP, infected cells were selected with 1 mg/mL puromycin
(Sigma, P7255). After 3 days, remaining cells were fixed for immunofluorescence staining, collected for RNA extraction and disso-
ciated to prepare MTs.
Lentiviral transduction for CX43 overexpression in primary SFs
Lentivirus expressing Cx43 (LV.hCMV-IE.HsGJA1.IRES.PurR.hHBVPRE) (Liu et al., 2018) was used to overexpress Cx43 in CTRL2
SFs WK12022. Briefly, one day after seeding 40000 cells/12-well, SFs were transduced with 2,5 ml viral particles (5*10^8 TU) in fresh
medium with 8 mg/mL polybrene overnight. Empty lentiviral vector (LV.hCMV-IE.IRES.PurR.hHBVPRE) was used as a control. 72 h
post-transduction, infected cells were selectedwith 1 mg/mL puromycin (Sigma, P7255). After 3 days, remaining cells were expanded
(1:3 ratio), then dissociated and replated for immunofluorescence staining and used to prepare MTs.
3D cardiac microtissue (MT) culture
Prior toMT formation, hiPSC-ECs (CTRL1, CTRL2) and hiPSC-CFs (CTRL1, CTRL2, ACM) were prepared as follows: 2-3 days before
MT formation, a vial of cryopreserved hiPSC-ECs and a vial of cryopreserved hiPSC-CFs were thawed and cultured either in BPEL
medium supplemented with VEGF on plates coated with fibronectin (hiPSC-ECs), or in FGM3 on uncoated plates (hiPSC-CFs). On
the day of MT formation (day 0), hiPSC-ECs, hiPSC-CFs, SFs, ACFs, Cx43-sh-RNA CFs, SFs Empty LV and SFs CX43 LV were de-
tached using TrypLE 1X for 5 min at 37C, 5% CO2, centrifuged for 3 min at 1100 rpm, resuspended in BPEL medium and counted.
hiPSC-CMs at day 14-21 (CTRL1, CTRL2) that showed > 80%purity, measured as the percentage of troponin positive cells by FACS,
were dissociated using the Multi Tissue Dissociation Kit 3 (Miltenyi Biotec) following the manufacturer’s instructions, resuspended in
BPEL medium and counted. For CMECs: cell suspensions were combined to a total of 5000 cells (85% cardiomyocytes and 15%
endothelial cells) per 50 mL BPELmedium supplemented with VEGF (50 ng/ml). For CMFs: cell suspensions were combined to a total
of 5000 cells (85% cardiomyocytes and 15% cardiac fibroblasts) per 50 mL BPEL medium supplemented with FGF2 (5 ng/ml). For
CMECFs: cell suspensions were combined to a total of 5000 cells (70% cardiomyocytes, 15% endothelial cells and 15% cardiac
fibroblasts) per 50 mL BPEL medium supplemented with VEGF (50 ng/ml) and FGF2 (5 ng/ml). MTs composed of primary fibroblasts
(ACFs, CTRL1 SFs, CTRL2 SFs, ACM SFs) were prepared as described for CMECFs. For all MTs, cell suspensions were seeded on
V-bottomed 96-well microplates (Greiner bio-one) and centrifuged for 10 min at 1100 rpm. MTs were incubated at 37C, 5%CO2 for
21 days with media refreshed every 3-4 days. Dibutyryl cAMP (dbcAMP) treatment was performed on CMECFs and CMEC SFs from
CTRL1 and CTRL2 in BPEL medium supplemented with 0.5 mM dbcAMP for 7 days (from day 14 to day 21). Analysis of all MTs was
performed after 21 days, unless otherwise indicated in Figure legends. For experiments that required cell dissociation, MTs were
incubated in 290 U/mg of pre-warmed collagenase type II (Worthington) in HBSS solution (Sigma Aldrich). Single cells were used
for either scRNaseq or seeded on 24-well Matrigel-coated plates on top of glass coverslips (10 mm diameter) for immunofluores-
cence and electrophysiology.
OCT cryosections of 3D microtissues
Microtissues were fixed in 4%PFA at RT for 20min and were embedded in Tissue-TekOCT compound (Sakura Finetek) for further
analysis. Thick frozen serial cross sections (8 mm) were processed for immunofluorescence staining.
Immunofluorescence analysis
For immunofluorescence staining, primary fibroblasts were dissociated using TrypLE 1X for 5 min at 37C, 5% CO2 and 20 3 10
3
cells/well were seeded on a 96-well/plate (plastic, 96-well Black/Clear tissue culture treated plate; Falcon). hiPSC-derived cells
were dissociated as above and seeded either on Matrigel- (CMs: 40 3 103) or fibronectin- (EPI: 20 3 103) or vitronectin- (CFs:
20 3 103) coated plates, on a 96-well/plate (plastic, 96-well Black/Clear tissue culture treated plate). MTs were dissociated as
above and 50 and 1003 103 single cells were seeded on 24-well Matrigel-coated plates, on top of glass coverslips (10mmdiameter).e5 Cell Stem Cell 26, 862–879.e1–e11, June 4, 2020
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other cell types) for 20 min in 4% paraformaldehyde, permeabilized for 10 min with PBS (Calcium, Magnesium, Thermo Fisher Sci-
entific) containing 0.1% Triton X-100 (Sigma Aldrich) and blocked for at least 1 h with PBS (Calcium, Magnesium) containing 10%
FCS. Primary antibodies were added overnight at 4C on a shaker. The following day, cells were washed 3 times with PBS (Calcium,
Magnesium) at room temperature, each time incubated for 10/15 min. Secondary antibodies were added for 1h at 37C and pro-
tected from light. Cells were washed three times with PBS (Calcium, Magnesium), each time incubated for 10 min and stained
with DAPI (Thermo Fisher Scientific) for 10 min at room temperature. Images were captured with an EVOS FL AUTO2 microscope,
using a 10x and 20x magnification objective. For dissociated MTs, images were captured with a Leica SP8WLL confocal laser-scan-
ning microscope, using a 63x magnification objective and Z stack acquisition. Whole mount immunofluorescence staining of 3D car-
diac MTs was performed as described previously (Giacomelli et al., 2017a, 2017b). Briefly, MTs were washed in PBS (Calcium, Mag-
nesium) on day 21 and fixed for 1h at 4C with 4% paraformaldehyde, washed 3 times in PBS (Calcium, Magnesium) and stored at
4C until processing. MTs were permeabilized for 30 min with PBS (Calcium, Magnesium) containing 0.2% Triton X-100 and blocked
for 2h in PBS (Calcium, Magnesium) containing 10% FCS. All incubations were at room temperature. Primary antibodies were added
overnight at 4C. The following day, MTswere washed 3 times with PBS (Calcium, Magnesium) at room temperature, each time incu-
bated for 10 min. Secondary antibodies were added overnight at 4C. The following day, MTs were washed 3 times with PBS (Cal-
cium, Magnesium) at room temperature, each time incubated for 20-30 min and then stained with DAPI (1:500) for 1h at room tem-
perature. MTs were mounted with ProLong Gold antifade Mountant (Thermo Fisher Scientific) onto microscope slides on top of
12 mm round, glass coverslips. Images were captured with a Leica SP8 WLL confocal laser-scanning microscope, using a 25x,
40x, or 100x objectives and Z stack acquisition or using Andor Dragonfly spinning disk confocal microscope with a 100x objective.
Transmission Electron Microscopy (TEM)
MTs were fixed for 1hr in 1.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) by adding an equal volume of double concentrated
(3%) fixative to the culturemedium. After rinsing theMTs three times in 0.1M cacodylate buffer, theywere postfixed in 1%OsO4/0,1M
cacodylate solution for 1h on ice. Next, MTs were dehydrated in 70% EtOH overnight. The next day, MTs were dehydrated in 80 and
90%EtOH for 10mins, and twice in 100%EtOH for 30min. MTswere then embedded in amixture of propylene oxide and EPON (2:1,
1:1 and 1:2, for 30min each followed by pure EPON for 60min.MTswere transferred in an embedding capsule and EPONwas added.
EPONwas allowed to harden for two days at 70C. Samples were sliced using a elementsix ultramicrotome knife (Drukker) in a Reich-
ert Ultracut S microtome (Leica) into 80 nm ultrathin slices and mounted on copper grids before being stained with saturated uranyl
acetate (20 ml) in the dark at room temperature for 10min. MTswere thenwashed ten times inmilliQ and twice in NaOH (0.01M). Next,
MTs were stained for 5 min with lead citrate (20 ml) and washed 10 times in 0.01%NaOH/MilliQ solution and ten times in milliQ before
being air-dried and imaged with a Twin electron microscope (Tecnai T12Twin, Fei, Eindhoven). Samples were imaged with the Gatan
camera (One View) by stitching several photographs together (Faas et al., 2012). Stitches and sarcomere length were analyzed using
Aperio ImageScope (version 12.3.2.8013, Leica). Quantitative analysis of sarcomere length was performed on TEM images by calcu-
lating the distance between consecutive Z-lines (distance from themiddle of one Z-line to themiddle of the next) using Aperio Image-
Scope. Statistical analysis was performed using GraphPad Prism 8.2.0.
Contraction analysis
MTs were seeded on 24-well Matrigel-coated plates on top of plastic 13 mm coverslips (Sarstedt). Movies of spontaneous or paced
MTs were acquired for at least 10 s at 37C either with a ThorLabs DCC3240M camera at 100 frames/sec and a 10 x objective phase
contrast objective (Leica Inverted microscope IBDE), using the ThorLabs uc480 software (v 4.20), either with a Leica Microsystems
LASAF6000microscope at 37Cand 5%CO2. For verapamil and Bay-K8644 experiments, videos ofMTswere acquired under perfu-
sion after 5min of incubation in baseline condition (Tyrode’s) or drug. During the last min of incubation,MTswere stimulated at 1.5 Hz,
with 12V/cm strength and 3 ms long stimulation pulse. For ACM and CX43 overexpression data, movies were recorded from MTs
paced at 1, 2 or 3 Hz and kept in their V-bottomed culture plate, at 37C and 5%CO2. Contraction data were obtained by analyzing
movies either with the MUSCLEMOTION ImageJ macro (ImageJ v. 2.0.0-rc-49) as described previously (Sala et al., 2018), or with
Vector Flow analysis. Contraction duration of spontaneously beatingMTswas normalized to their spontaneous beating rate: Normal-
ized contraction duration = contraction duration / sqrt (IBI).
For ACM data, MT pacing experiments were analyzed using an R script calculating the contraction rate and the coefficient of vari-
ation (CV) of contraction amplitudes. MTs were classified as correctly following the applied stimulation frequency when the rate was
equals to the pacing rate ± 15% and when the contraction amplitude CV was lower than a chosen cutoff (28%, which accounts for
random amplitude variations).
The Horn-Schunck Vector Flow analysis method was used to detect changes in pixel displacements during contraction of the mi-
cro tissues in general according to ref. (Hayakawa et al., 2012). The analysis package was developed with LabVIEW Motion and
Vision (National instruments U.S.A). Images were collected at 100 frames/sec with a Thor Labs camera DCC3260M (Thorlabs
GmbH 85221Munich, Germany) and a 10X objective phase contrast objective (Leica Invertedmicroscope IBDE). Cells were perfused
with a Tyrode solution at 37C and paced at 1 Hz. Tyrode’s contained (in mM): 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1.0 MgCl2, 5.5 glucose,
5.0 HEPES; pH 7.4 (NaOH). The mm/pixel was calibrated and used to compute the horizontal and vertical velocity and the resultant
velocity. Binning of the vectors was carried out over 153 15 mm2 at an average 300x300 mm selection. Of each image, the maximum
velocity bin of all bins was selected to compute the resulting contraction/relaxation profiles. The maximum velocity was selectedCell Stem Cell 26, 862–879.e1–e11, June 4, 2020 e6
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bins and plotted at the contraction/relaxation trajectories in order to quantify the deviations from the peak values. The direction of the
contraction was calculated computing the angular direction of the vertical and horizontal components (arc tangent). Experiments
were analyzed over at least 5 repetitive contractions per experimental condition. From the contraction/relaxation profile, five param-
eters were analyzed. The velocity of the upstroke (mm/sec) the acceleration of the upstroke (mm/sec2), the velocity of relaxation (mm/
sec), the acceleration of relaxation (mm/sec2) and the beat duration. For all individual data points presented, data from at least 3 sepa-
rate MTs were pooled (SD) or individual measurements were averaged to obtain the number of observations (SEM). From the
computed vectors, line integrals were computed with the Advanced Plotting Toolkit (National Instruments).
Sharp Electrode Electrophysiology
MTs were seeded on 24-well Matrigel- coated plates, on top of plastic 13 mm coverslips (Sarstedt). CMECFs were manually cut as
necessary into smaller pieces before measurement. Sharp electrodes were fabricated with a Sutter Flaming Brown puller 97 (Sutter
Instruments, CA, USA). Electrodes were filled with 3M KCl having a final resistance of 80 – 100 MOhm (estimated tip diameter of
0.2 mm). ADagan intracellular IX1 amplifier with a Buzz unit (DaganMinneapolisMNUSA) was used.MTswere perfusedwith Tyrode’s
solution at 37C, gently touched by the electrodes and penetrated using the zap function of the amplifier Buzz unit using an MP-200
micromanipulator (Sutter Instruments, CA, USA). APs were stored with an Axon Digidata 1322A and pClamp 10 software at 10 kHz
(Axon Molecular Devices USA).
Patch clamp electrophysiology
For dibutyryl cAMP (dbcAMP) experiments in 2D culture, CTRL1 hiPSC-CMs were dissociated with TrypLE 1X for 5 min at 37C, 5%
CO2, centrifuged for 3 min at 1100, plated on glass coverslips (10 mm diameter) coated with Matrigel at a density of 40.000 cells/well
and cultured for 72 hr either in Pluricyte medium (NCardia) (CTRL) or in medium containing 0.5 mM dbcAMP before analysis. Patch
clamp measurements were performed on small groups of cells (10-20) with Axopatch 200B patch clamp amplifier at 5 kHz in the fast
current-clampmode. Recordings only with seal resistances of 2.5 GOhm or higher were selected for further analysis. Data were digi-
tized with a DigiData 1322A at 10 kHz under control of Clampex 10.0 software (Molecular Devices Axon Instruments U.S.A.). Pipets
used had a resistance of 2.4 MOhm. Pipet buffer composition: K-gluconate 125 mM; KCl 20 mM; NaCl 5 mM; HEPES 10 mM
adjusted to pH 7.3 with KOH. Amphotericin-B (Sigma-Aldrich U.S.A) was added to the pipet buffer before start of the measurements
at a concentration of 3 mg/ml from a DMSO stock of 0.6 mg/ml (light protected). Cells were continuously perfused in a perfusion
chamber at 37C (Cell MicroControls Norfolk VA, U.S.A.) with Tyrode’s solution. For MT experiments: single cells were dissociated
from all groups of MTs in parallel on day 21. Cells were re-plated on top of glass coverslips (10 mm diameter) at low density to obtain
isolated single cells. After 1 week, coverslips were placed onto the stage of an invertedmicroscope for patch clamp recordings. Cells
were kept at 36 ± 1C and perfused with Tyrode’s physiological solution containing (mmol/L): 140 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2,
5.5 D-glucose, 5 HEPES-NaOH, pH 7.4. Cardiomyocytes were selected based on morphology and spontaneous contraction. APs
were recorded with Axopatch 200B amplifier, digidata 1440A and pClamp10.7 software (Molecular Devices) using patch clamp in
whole cell perforated patch configuration and current clamp mode. The pipette solution contained (mmol/L): 125 K-gluconate, 20
KCl, 10 NaCl, 10 HEPES, 0.5 amphotericin B (Sigma), pH 7.2. APs were recorded by stimulating for 2 ms at 1 Hz both without
and with dynamic clamp technique for computed IK1 injection, as previously shown (Verkerk et al., 2017). AP duration, amplitude
and membrane resting potential were analyzed from recordings without IK1 dynamic injection, whereas Vmax was analyzed on dy-
namic clamp recordings to reduce variability due to different resting membrane potentials. The percentage of APs with a ‘‘notch’’
was obtained using R script by calculating the minimum derivative value of AP traces in the peak region. Notches were identified
for derivative values < 3, a cut-off set to account for trace random oscillations. Analysis was performed using RStudio, OriginPro
(Origin Lab) 2016 and GraphPad Prism 8.2.0.
Calcium analysis
MTswere seeded on aMatrigel-coated 96-well/plates (plastic, 96-well Black/Clear tissue culture treated plate), and loadedwith 5 mM
Fluo-4 AM (Thermo Fisher Scientific) for 30 min at 37C. Medium was changed (BPEL) and left for 30 min at 37C before recordings.
For recordings, MTs were stimulated at 1.5 Hz on a Leica Microsystems LAS AF6000 microscope and recorded for at least 10 s. All
calcium experiments were performed at 37C and 5% CO2. Analysis was performed using a custom-made ImageJ macro to imple-
ment the calculation of dF/F as described by Takahashi et al. (1999). Briefly, the background of the recording was selected outside
the MT. The maximum projection of the recording was determined to automatically select the area of the MT by thresholding the
result at the overall mean intensity plus standard deviation. Finally, a custom-made Labview programwas used to detect the kinetics
and calcium transients. For caffeine experiments, MTs were plated and loaded as described above. MTs were stimulated at their
averaged spontaneous beating frequency. After 4 calcium transients, stimulation was stopped and 50 mM caffeine added immedi-
ately and directly to the culture medium. Analysis was performed as described above. To calculate the caffeine induced amplitude
increase, the amplitude of the first peak after caffeine addition was divided by the average of the four peaks before caffeine.
Drug preparation
Verapamil hydrochloride (Tocris), Bay-K8644 (Tocris), caffeine (Sigma-Aldrich) and dbcAMP (Sigma-Aldrich) were dissolved in
DMSO following the manufacturer’s instructions. Stock solutions were freshly prepared before experiments.e7 Cell Stem Cell 26, 862–879.e1–e11, June 4, 2020
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Direct cAMP Enzyme-linked Immunosorbent Assay (ELISA) was performed using a direct cAMP ELISA kit (Enzo Life Sciences)
following the manufacturer’s instructions. Prior to assay procedure, 240 MTs/condition were pooled and lysed in 0.1M HCL and
stored at 20C before experiment.
Oxidative respiration and glycolytic acidification
Oxidative respiration and glycolytic acidification were measured with Seahorse XF-96 Analyzer (Agilent). MTs were collected into a
15mL Falcon tube andwashed three times in assaymedium+ 0.2%BSA. 4h beforemeasurement, fourMTs (or five for the CMECMT
group) per well were plated on 96-well Matrigel-coated (0.167 mg/ml) plates. Measurements were made in minimal DMEM (Sigma)
supplemented with 15 mM glucose (Sigma-Aldrich), 2 mM pyruvate (Thermo Fisher Scientific) and 1 mM L-glutamine (Thermo Fisher
Scientific) (assay medium). For Mitochondrial stress test, the following drugs were diluted in assaymedium: 3.5 mMOligomycin, 4 mM
FCCP, 2 mM Antimycin A and 2 mM Rotenone (all from Sigma-Aldrich). For the glycolytic stress test, MTs were plated in medium
without glucose and the injections contained 15 mM glucose, 3.5 mMOligomycin, and 100 mM 2-DG (Sigma-Aldrich). Normalization
was performed by lysing theMTswith a chloride-based lysis buffer (10mMTris, 1mMEDTA, 50mMKCl, 2mMMgCl2) supplemented
with 200 mg/ml Prot K, for 2 h at 60C. DNA content was measured using a Picogreen assay (Thermo Fisher Scientific). Analysis was
performed using R and R-studio.
Nuclear Magnetic Resonance spectroscopy (NMR)
Two aliquots of culture medium were collected from each sample, first immediately after refreshing the culture medium 24h before
harvesting and then right before harvesting. All aliquots were immediately mixed with 2 volumes of cold methanol (70C) and stored
at 80C. For analysis of intracellular metabolites, 60 MTs/condition were pooled together and spun down for 5 s, culture medium
was aspirated and pellets were washed with ice-cold PBS. After 5 s of mild centrifugation, PBS was aspirated and MTs were
immersed in liquid nitrogen to completely quench metabolic activity. Intracellular metabolites were extracted by addition of
0.6 mLmethanol/chloroform/water, 6.75:0.75:2.5 (v/v/v) and repeating cycles of 10 s of vortexing, 1 min sonication and 1min resting
on ice, for a total of 15 min. Subsequently, all samples (culture medium and MT extracts) were centrifuged for 20 min at 180003 g at
4C and collected supernatants were dried under a gentle flow of nitrogen. NMR samples were prepared by dissolving the dried
material with 0.22 mL of 0.15M phosphate buffer (pH 7.4) in deuterated water containing 0.05mM trimethylsilyl propionic-d4-sodium
salt (TSP-d4) as internal standard for NMR referencing and quantification. An 1D
1H-NMR spectrumwas collected for each sample on
a 14.1 T (600 MHz for 1H) Bruker Avance II NMR, using the 1D-NOESY experiment with pre-saturation as implemented in the spec-
trometer library (pulse sequence: noesygppr1d). All spectra were processed to correct the phase and baseline and imported in Che-
nomx NMR suite 8.4 for quantification of metabolites. All concentrations were normalized to the total protein mass of each sample.
Details of the experimental procedure and NMR analysis can be found in Kostidis et al. (2017).
Gene expression (qPCR)
For qPCR, total RNAwas purified using the NucleoSpin RNA Kit (Macherey- Nagel) according to the manufacturer’s protocol. 1 mg of
RNA was reverse transcribed by using the iScript-cDNA Synthesis kit (Bio-Rad). Expression profiles of genes of interest were deter-
mined by qPCR using either 8ng/ml of cDNA (MTs experiments) or 6 ng/mL of cDNA (all other experiments), and the iTaq Universal
SYBR Green Supermixes (Bio-Rad). Gene expression was assessed by a Bio-Rad CFX384 real time system. Gene expression levels
were normalized to RPL37A and HARP housekeeping genes. Results were analyzed by using the DCt method. For qPCR on MTs,
60 MTs/condition were pooled together. Primer sequences are provided in Table S6.
Gene expression (bulk RNA-sequencing)
Whole-genome transcriptome data were generated at BGI (Shenzhen, China) using the Illumina Hiseq4000 (100bp reads). Raw data
were processed using the LUMCBIOPETGentrap pipeline (https://github.com/biopet/biopet), which consists of FASTQpreprocess-
ing, alignment and read quantification. Sickle (v1.2) was used to trim low-quality read ends (Joshi and Fass, 2011). Cutadapt (v1.1)
was used for adapters clipping (Martin, 2011), reads were aligned to the human reference genome GRCh38 using GSNAP (gmap-
2014-12-23) (Dobin et al., 2013; Wu and Nacu, 2010) and gene read quantification with htseq-count (v0.6.1p1) against the Ensembl
v87 annotation (Anders et al., 2015). Gene length and GC content bias were normalized using the R package cqn (v1.24.0) (Wu and
Nacu, 2010). Median chromosome X and Y expression were used to verify the sex of included samples. Genes were excluded if the
number of readswas below 5 inR 90%of the samples. The final dataset comprised gene expression levels of 36 samples and 22,227
genes. Differentially expressed genes were identified using generalized linear models as implemented in edgeR (McCarthy et al.,
2012). P values were adjusted using the Benjamini-Hochberg procedure and PFDR % 0.05 was considered significant. Analyses
were performed using R (version 3.4.4). Figures were produced with the R package ggplot2 (v2.2.1). Consensus clustering of
selected DEGs was performed with CancerSubtypes R package (Xu et al., 2017). Clustering was iterated 500 times for K clusters
in the range 2 to 10. Heatmap of genes in all 8 clusters was generated using a heatmap function of NMF R package (Gaujoux and
Seoighe, 2010). GO and KEGG pathway enrichment for each cluster of genes was performed using compareCluster function of clus-
terProfiler R package (v3.10.1) (Yu et al., 2012) and q% 0.05 was considered significant.Cell Stem Cell 26, 862–879.e1–e11, June 4, 2020 e8
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Pre-processing, clustering and tSNE
For clustering, replicates of CMs and CMECFs were pre-processed separately. In both cases, undetected genes (genes with a count
of one in less than two cells) and the 50 cells with the lowest number of transcripts were removed from further analysis. This resulted in
6810 cells and 12823 genes for the CMs dataset, and 9497 cells and 13958 genes for the CMECFs dataset. Then, k-nearest neigh-
bors (knn) smoothing was performedwith the python package kNN-smoothing (Version 2.1, (Wagner et al., 2018)) using k = 15, d = 10
and dither = 0.05. Each replicate was normalized individually with the scran package in R (V 1.10.1) using themethod described in Lun
et al. (2016). The 10%most highly variable genes (HVG) for each replicate were calculated with scran after excluding ribosomal genes
(obtained from the HGNCwebsite without any filtering for minimum gene expression), stressed genes (van den Brink et al., 2017) and
mitochondrial genes. Batch effect correction between replicates was performed with a mutual nearest neighbors (MNN)- based
approach (Haghverdi et al., 2018) implemented in the scran package. (Here we used log transformed, knn-smoothed and normalized
count data of the 10%most HVG that were present in all replicates). The MNN algorithm was run with d = 50. Hierarchical clustering
was performed onMNN corrected counts using Pearson correlation as distance measure andWard linkage. For the CM dataset, the
hierarchical clustering tree was cut at height 40 which resulted in 2 clusters. For CMECFs, the hierarchical clustering tree was cut at
height 12 which resulted in 4 clusters. Among the clusters thus defined, cardiomyocytes were identified by knownmarker genes from
the literature. Then, the cardiomyocytes from each of the four datasets were combined into one dataset comprising 8405 cells and
11472 genes in total. The raw data from these cells was pre-processed again, as described above using the same parameters, where
normalization and calculation of HVGwas now performed simultaneously for all cardiomyocytes. No batch effect correction was per-
formed. T-distributed stochastic neighbor embedding (tSNE) was performed using the R package Rtsne. We used Freeman-Tuckey
transformed and MNN corrected values to calculate the Pearson correlation as a distance measure for the tSNE.
Differential expression analysis
The R package edgeR (V 3.24.1, (Robinson et al., 2010)) was used to perform differential expression analysis. We used counts and a
negative binomial distribution to fit the generalized linear model. The covariates were comprised of four binary dummy variables that
indicate the four cardiomyocyte populations and a variable that corresponds to the total number of counts per cell. Finally, p values
for a contrast between CMECFs and CMs (CMECFs – CMs) were obtained and adjusted for multiple hypothesis testing with the
Benjamini-Hochberg method.
Comparison to bulk RNA-sequencing data
Bulk samples were obtained from dataset GEO: GSE62913 (Kuppusamy et al., 2015). For principal component analysis (PCA) the
intersection of the 10% most HVG of the single cell cardiomyocyte dataset and genes expressed in the bulk samples were used.
Each of the three datasets (merged cardiomyocytes from the scRNA-seq dataset, bulk samples of CMs, CMECs and CMECFs,
bulk samples from Kuppusamy et al., 2015) were Freeman-Tuckey transformed and scaled individually before calculating the prin-
cipal components.
Western blot
hiPSC-CFs and EPI generated from CTRL1, CTRL2 and ACM were lysed on ice in protein extraction buffer (10 mM Tris-HCl pH 7.4,
150 mM NaCl, 1% Igepal CA630, 1% sodium deoxycholate, 0.1% SDS (Sodium Dodecyl Sulfate) and 1% Glycerol supplemented
with protease inhibitor mix. Total lysates were quantified using BCA protein kit (Thermo Fisher Scientific) following manufacturer’s
instructions. Total proteins (30 mg) were resolved by SDS-PAGE gel (4%–15% Criterion Precast Gel, Bio-Rad) and transferred to
PVDF membrane (Bio-Rad). The membrane was blocked by incubation with TBS 0.1% Tween, 5% non-fat dry milk for 1 h at
room temperature (RT). The membrane was then incubated overnight at 4C with primary commercial antibodies against PKP2
and GAPDH. The membrane was washed with TBS 0.1% Tween and incubated 1 h at RT with the appropriate HRP-conjugated sec-
ondary antibody (Cell Signaling). Detection was performed using the enhanced chemiluminescence system (SupersignalWest Dura
Extended Duration Substrate, Thermo Fisher Scientific) and images were acquired with the ChemiDocMP Imaging System (Bio-rad).
Acquired images were quantified using Image Lab software 5.2.1 (Bio-Rad).
Bright field images
Bright field images were acquired with a Nikon DS- 2MBW camera connected to a Nikon Eclipse Ti-S microscope, controlled by the
Nikon NIS-Element BR software. Lens magnification was 4x with a PhL contrast filter.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantitative sarcomere analysis by immunostaining
Sarcomere length
3D cardiac MTs and dissociated MTs were stained for Z-bands (ACTN2) and sarcomere length was analyzed on images captured by
confocal microscope using standard analysis plugin in open-source Fiji Software, ImageJ.
Sarcomere organization
Z-band density and bidimensional organization indicating sarcomere alignment were evaluated on 3D cardiac MTs stained for
ACTN2 and acquired by confocal microscope. The analysis of sarcomere alignment was performed using a plugin based on Fast
Fourier Transform (FFT) algorithm (Fiji Software, ImageJ) as previously described (Pioner et al., 2016). Briefly, the peak componentse9 Cell Stem Cell 26, 862–879.e1–e11, June 4, 2020
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the area under the first order peak for the total area of the power spectrum profile.
Quantitative CX43 analysis by immunostaining
Quantification of immunostaining was preformed using the open-source software Cellprofiler (Bray et al., 2015; Carpenter et al.,
2006). Objects were identified in the pipeline using otsu thresholding to segment DAPI positive nuclei or CX43 positive spots in
the respective channels to provide total number of CX43 per cell. For quantification of CX43 and PKP2 intensity, the positive staining
was first outlined using Sobel edge-finding method, then total intensity of the image enclosed by the defined edges was quantified
and normalized to the number of nuclei. For quantification of intensity at cell junctions only, an additional step tomask the area inside
the cell was applied, so that the only defined areas at the cell junctions were quantified.
To quantify SMApositive cells, non-specific small bright objects were first identified usingOtsu’s thresholdingmethod and cell size
and used to mask non-specific signal in the image. Next, using Otsu’s thresholding and cell size, parameters were used to segment
SMA positive and DAPI positive cells to obtain the percentage of SMA positive cells per image.
3D quantification of CX43 in MTs was preformed using the spot detection function of the IMARIS software.
Computational framework for quantitative analysis
We developed a computational framework in-house for semi-automated quantification of 3D stack reconstructions from confocal
sections, which combines computer graphic algorithms, image processing, segmentation, ellipsoidal fitting and 3D object recon-
struction based on area superposition. The framework was developed combining Java scripts in Fiji (Schindelin et al., 2012) and
MATLAB (Mathworks Inc.). The sequence of instructions implemented in the framework is the following:
Segmentation of nuclei channel:
1. Definition of Kernel Radius (KR): User defines the radius of the kernel required to perform several of the image processing al-
gorithms used in the framework. This parameter is defined attending the minimal radius of interest objects in the image. To
analyze images of MTs, a KR of 5 pixels was used.
2. Lighting Homogenization: To reduce differences in intensity along x and y axis of each confocal section, a gray-scale morpho-
logical subtraction using an opening image with large kernel (Sreedhar and Panlal, 2012) (5*KR) was performed.
3. Local Background Subtraction: To remove the background intensity, a local threshold defined by the local median intensity (8x
KR x KR) was used.
4. Enhancing Object definition: A sequence of filters was applied to remove noise and increase the definition of the boundaries of
each object (Median filter, Gaussian Blur, Maximum Filter).
5. SeedGeneration: A binary copy of each image was generated using themedian as threshold for each slice. Euclidean Distance
Map (EDT) was performed in the binary image to generate the primordium points (seeds) for each object.
6. Identification of objects: Segmentation was completed from seeds using a flood fill algorithm. Objects smaller than KR*KR
were not considered. Objects n times larger than a threshold defined by the user were divided into n independent objects.
3D reconstruction of nuclei:
After identification of each 2D object in each section of the sample, our framework identified each segmented object in each section
of the sample with a 3D object in the stack. An example of MT reconstructed digitally is shown in Figure S1D. This script is used to
generate the data for Figure S1B (right panel). This was performed as follows:
1. Ellipsoidal fitting: Each segmented object was fitted to an ellipse, with area and orientation depending on the dimensions and
characteristics of the object.
1. Overlapping area: Interactions between segmented objects of adjacent planes were identified based on the amount of over-
lapping between their fitted ellipses. As a first approximation, an interaction between 2D objects was established if their fitted
ellipses overlapped.
2. Initial objects and elongation: If a 2D ellipse did not have an interactionwith an object in the previous section, it was identified as
the start of a new 3D object. Starting from each initial section, the next section of the object was identified based on the
maximal overlap of the ellipses. This reconstruction was performed iteratively until the final section of each 3D object was iden-
tified.
3. Final objects: The end of a 3D object was defined by an average size of the object in the z-direction, estimated by the size of the
3D projections of each image (this length in the Z axis was referred as KZ).
4. Parameter analysis: The desired values of each 3D object in the 3D stack were extracted and listed for quantitative analysis
(volume, location, orientation, distance to neighbors).
Identification of each cell type:
The information of the marker intensity based on immunostaining was used to determine the identity of each nucleus. This script is
used to generate the data for Figure S1C. For the classification of cellular composition of MT in different conditions analyzed, the
intensity of the following markers was used: TNN1, COL1A1, CD31.Cell Stem Cell 26, 862–879.e1–e11, June 4, 2020 e10
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defined, the following tasks were defined:
1. Noise removal: Noise in the form of small pixel-to-pixel variations was removed using a Gaussian blur filter in the sections. Fil-
ters were applied with a user defined KR.
2. Intensity normalization: Intensity of all channels containing the identity markers was normalized.
3. Threshold definition: A threshold value for each identity marker was defined in correlation with the others to define the most
probable identity of this object. These thresholds were defined by the user based on the characteristics of the staining and
the nature of each identity marker.
4. Nuclei classification: Identification of each 3D object was defined as the most frequently occurring identity of all its ellipsoidal
2D sections. If themost frequent staining was TNN1 the cell was identified as cardiomyocyte; COL1A1 corresponded to a fibro-
blast identity; CD31 to an endothelial phenotype.
Identification of proliferative cells:
For the identification of proliferative and fibroblast cells at day 7 and 21, identities were established based on presence or absence of
a staining. This script is used to generate the data for Figure S1E. In case cells could not be assumed as positive for an identity
marker, the approach used was:
1. Noise removal: Noise in the form of small pixel-to-pixel variations was removed using a Gaussian blur filter in the sections. Fil-
ters were applied with a user defined KR.
2. Morphological operation: Presence of fibers were removed by applying an opening filter using as structuring element a line in
135 degrees respect the horizontal (Legland et al., 2016). Filters were applied with a user defined KR.
3. LightningHomogenization: To reduce differences in intensity along x and y axis of each confocal section, a gray-scalemorpho-
logical subtraction using an opening image with large kernel (Sreedhar and Panlal, 2012) (5*KR) was performed
4. Background subtraction: Subtraction of values lower than the result of the sum of the average and standard deviation were
performed in each slice.
5. Nuclei classification: Classification of nuclei based on the average intensity value in fitted 2D ellipses was performed for all
channels. A cell with an average intensity of KI67 higher than zero was assumed as proliferative. A cell with an average intensity
of COL1A1 higher than zero was considered a fibroblast.
Measurement of average distance:
This script was used to generate the data for Figure S1F, by computing the centroid of each 3D object in the stack as follows:
1. Distance between nuclei in the sample and its 12 closest neighbors was computed. The median value was calculated for each
nuclei as the most probable distance.
2. Average distance (as well as standard deviation of the average distance) between all cells in the sample was calculated as the
average value of all the medians for the whole MT.
Measurement of volume:
This script was used to quantify the average volume of TNN1+ nuclei plotted in Figure S1G as follows:
1. Each 3D object in the stack was fitted to an ellipsoid. The KZ (length in the z axis) in the different samples analyzed was varied
based on the average size of 3D objects in the Z-direction: KZ = 18 for images corresponding to day 7 and 21 without fibro-
blasts; 10 for images corresponding to day 7 and 21 with fibroblasts; 46 for images corresponding to CMECs, whereas 36 for
the rest of the images.
2. TNN1+ cells were identified using the approach explained above.
The volume of each cell was calculated from the semi-axis distance of each MT.
Statistics
Detailed statistics and statistical significance are indicated in each figure legend. Results with p values p < 0.05 were considered
statistically significant. Briefly, One-way ANOVA, two-way ANOVA, Student’s t test, for paired or unpaired measurements were
applied as appropriate to test for differences in means between groups/conditions. Data are expressed and plotted as the
Mean ± SEM orMean ± SD as indicated in figure legends. The sample size used in each experiment is indicated in the figure legends.
Statistical analysis was performed using GraphPad Prism 8.2.0 and RStudio.e11 Cell Stem Cell 26, 862–879.e1–e11, June 4, 2020
